Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

☐

Fee paid previously with preliminary materials.

☐

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.

It is a pleasure to invite you to our Annual Meeting of
Shareholders on Tuesday, May 8, 2018 at 9:00 a.m. The meeting will be held at The Jefferson Hotel, Empire Room, 101 West Franklin Street, Richmond, Virginia, 23220. Directions to The Jefferson Hotel are on the last page of the proxy statement.

The Notice of 2018 Annual Meeting of Shareholders and Proxy Statement describe the items of business for the meeting. In
addition to considering these matters, we will review significant accomplishments and events since our last shareholders meeting as well as future opportunities and initiatives we intend to pursue. Our Board of Directors and management team
will be there to discuss items of interest and to answer any questions.

The Notice of 2018 Annual Meeting of Shareholders
contains instructions on how to access our proxy materials and our 2017 Annual Report/Form 10-K over the Internet as well as how shareholders can receive paper copies of such documents, if they so desire.

You may vote your shares by the Internet or by telephone or, if you prefer, you may request paper copies of the proxy
materials and submit your vote by mail by following the instructions on the proxy card. We encourage you to vote via the Internet. Whichever method you choose, your vote is important so please vote as soon as possible. All of us at
Owens & Minor appreciate your continued interest and support.

Whether or not you plan to attend the annual meeting, please vote your shares promptly, as instructed in the Notice of Internet Availability of Proxy Materials, by the Internet or by telephone. You may
also request a paper proxy card to submit your vote by mail, if you prefer. We encourage you to vote via the Internet.

The Annual Meeting of Shareholders of Owens & Minor, Inc. (the Company or Owens & Minor) will be
held on Tuesday, May 8, 2018 at 9:00 a.m. EDT at The Jefferson Hotel, Empire Room, 101 West Franklin Street, Richmond, Virginia, 23220.

The purposes of the meeting are:

1.

To elect the 10 directors named in the attached proxy statement, each for a one-year term and until their respective successors
are elected and qualified;

2.

To approve the Owens & Minor, Inc. 2018 Stock Incentive Plan;

3.

To ratify the appointment of KPMG LLP as the Companys independent registered public accounting firm for the year ending December 31, 2018;

4.

To conduct an advisory vote to approve the compensation of the Companys named executive officers; and

5.

To transact any other business properly before the annual meeting.

Shareholders of record as of March 13, 2018 will be entitled to vote at the annual meeting.

Your attention is directed to the attached proxy statement. The Notice of Internet Availability of Proxy Materials is being distributed on or about March 26, 2018. This proxy statement, the proxy
card and Owens & Minors 2017 Annual Report/Form10-K are being furnished on the Internet on or about March 26, 2018.

Proxies are being solicited by the Board of Directors for purposes
of voting on the following proposals and any other business properly brought before the meeting:

Proposal 1:

Election of the 10 directors named in this proxy statement, each for a one-year term and until their respective successors are
elected and qualified.

Proposal 2:

Approval of the Owens & Minor, Inc. 2018 Stock Incentive Plan.

Proposal 3:

Ratification of KPMG LLP as the Companys independent registered public accounting firm for the year ending December 31, 2018.

Proposal 4:

Advisory vote to approve the compensation of our named executive officers.

Who is Entitled to Vote

Shareholders of Owens & Minor, Inc. (the
Company or Owens & Minor) as of the close of business on March 13, 2018 (the Record Date) are entitled to vote. Each share of the Companys common stock (Common Stock) is entitled to
one vote with respect to each matter to be voted upon at the meeting. As of March 13, 2018, 61,822,277 shares of Common Stock were issued and outstanding.

How to Vote

You can vote via the Internet, by telephone or by mail.

By Internet. You may vote via the Internet by following the specific instructions on the Notice of Internet Availability of
Proxy Materials. Shareholders who have requested a paper copy of a proxy card by mail may submit proxies over the Internet by following the instructions on the proxy card. We encourage you to vote via the Internet. If your shares are held by
your bank or broker in street name, please refer to the instruction form that you receive from your bank or broker or contact your bank or broker to determine whether you will be able to vote via the Internet.

By Telephone. You may vote by telephone by calling the toll-free number on the proxy card and following the instructions.
Shareholders will need to have the control number that appears on their notice available when voting. If your shares are held by your bank or broker in street name, please refer to the instruction form that you receive from your bank or broker or
contact your bank or broker to determine whether you will be able to vote by telephone.

By Mail. Shareholders who have requested a paper copy of a proxy card by
mail may submit proxies by completing, signing and dating the enclosed proxy card and returning it in the postage-paid envelope provided.

However you choose to vote, you may revoke a proxy prior to the meeting by (1) submitting a subsequently dated proxy by any of the methods described
above, (2) giving notice in writing to the Corporate Secretary of the Company or (3) voting in person at the meeting (attendance at the meeting will not itself revoke a proxy).

What Happens if You Do Not Make Selections on Your Proxy

If your proxy contains specific
voting instructions, those instructions will be followed. However, if you sign and return your proxy card by mail or submit your proxy by telephone or via the Internet without making a selection on one or more proposals, you give authority to the
individuals designated on the proxy card to vote on the proposal(s) for which you have not made specific selections or given instructions and any other matter that may arise at the meeting. If no specific selection is made or instructions given, it
is intended that all proxies that are signed and returned or submitted via telephone or Internet will be voted FOR the election of all nominees for director, FOR approval of the 2018 Stock Incentive Plan, FOR the
ratification of KPMG LLP as our independent registered public accounting firm in 2018 and FOR the approval, on an advisory basis, of the compensation of our named executive officers (together, the NEOs, and, individually, an
NEO).

Whether Your Shares Will be Voted if You Dont Provide Your Proxy

Whether your shares will be voted if you do not provide your proxy depends on how your ownership of shares of Common Stock is registered. If you own your
shares as a registered holder, which means that your shares of Common Stock are registered in your name, and you do not provide your proxy, your shares will not be represented at the meeting, will not count toward the quorum requirement, which is
explained below, and will not be voted.

If you own your shares of Common Stock in street name, your shares may be voted even if you do not
provide your broker with voting instructions. Brokers have the authority under New York Stock Exchange (NYSE) rules to vote shares for which their beneficial owner customers do not provide voting instructions on certain
routine matters. When a proposal is not a routine matter and the brokerage firm has not received voting instructions from the beneficial owner of the shares with respect to that proposal, the brokerage firm cannot vote the shares on that
proposal. This is called a broker non-vote.

The Company believes that only the proposal to ratify the
appointment of KPMG LLP as the Companys independent registered public accounting firm for 2018 is a routine matter for which brokerage firms will have discretionary voting power if you do not give voting instructions with respect to this
proposal. The proposal to elect directors, the proposal to approve the 2018 Stock Incentive Plan, and the proposal to approve, on an advisory basis, the compensation of our NEOs, are non-routine matters for
which brokerage firms will not have discretionary voting power and for which specific voting instructions from their customers are required. As a result, brokerage firms will not be allowed to vote on these
non-routine matters on behalf of their customers if the customers do not return specific voting instructions.

What Constitutes a Quorum

A majority of the outstanding shares of Common Stock present or
represented by proxy constitutes a quorum. A quorum is required to conduct the annual meeting. If you vote your proxy, you will be considered part of the quorum. Abstentions and shares held by brokers or banks in street name (broker
shares) that are voted on any matter are included in the quorum. Broker shares that are not voted on any matter will not be included in determining whether a quorum is present.

Election of Directors. The affirmative vote of a majority of the votes cast at the meeting is required for the election of each director. A majority of votes cast means that
the number of votes cast FOR a nominees election must exceed the number of votes cast AGAINST that nominees election. Abstentions and broker non-votes will not be counted as
votes cast and will have no effect on the results of this vote.

Approval of 2018 Stock Incentive Plan. The
approval of the 2018 Stock Incentive Plan requires the affirmative vote of a majority of the votes cast on this proposal. Abstentions will be considered as votes cast under the rules of the NYSE and will have the effect of a vote against this
proposal for purposes of the rules of the NYSE. Broker non-votes will not be counted as votes cast on this proposal and will have no effect on the results of this vote.

Ratification of Appointment of KPMG LLP. The appointment of KPMG LLP will be ratified if the votes cast FOR
this proposal exceed the number of votes cast AGAINST this proposal. Abstentions will not be counted as votes cast on this proposal and will have no effect on the results of this vote. There should be no broker non-votes because this is considered a routine matter under the rules of the NYSE.

Advisory Vote to
Approve Executive Compensation. The compensation of our executive officers named in the Summary Compensation Table will be approved on an advisory basis if the votes cast FOR this proposal exceed the number of
votes cast AGAINST this proposal. Abstentions and broker non-votes will not be counted as votes cast on this proposal and will have no effect on the results of this vote.

How to Obtain a Paper Copy of the Proxy Materials

Shareholders will find instructions about how to obtain a paper copy of the proxy materials on the notice they received in the mail about the Internet availability of proxy materials.

What it Means if You Get More Than One Notice about the Internet Availability of Proxy Materials

Your shares are probably registered differently or are held in more than one account. Please vote all proxies to ensure that all your shares are voted.
Also, please have all of your accounts registered in the same name and address. You may do this by contacting our transfer agent, Computershare, Inc., at 1-866-252-0358.

Costs of Soliciting Proxies

Owens & Minor will pay all costs of this proxy solicitation. The Company has retained Georgeson, LLC to aid in the distribution and solicitation
of proxies for approximately $6,000 plus expenses. The Company will reimburse brokers and other custodians, nominees and fiduciaries for their expenses in forwarding proxy and solicitation materials.

CORPORATE GOVERNANCE

General. The Company is managed under the direction of the Board of Directors, which has adopted Corporate Governance Guidelines to set forth certain corporate governance
practices. Each year, we review our corporate governance policies and practices relative to applicable laws, including the Dodd-Frank Wall Street Reform and Consumer Protection Act and the Sarbanes-Oxley Act of 2002 and rules and regulations
promulgated thereunder or adopted by the Securities and Exchange Commission (SEC) and the NYSE, the exchange on which the Common Stock is listed, as well as the policies and practices recommended by groups and authorities active in
corporate governance.

Corporate Governance Materials. The Companys
Bylaws, Corporate Governance Guidelines, Code of Honor and the charters of the Audit Committee, the Compensation & Benefits Committee (the Compensation Committee), and the Governance & Nominating Committee are available
on our website at http://www.owens-minor.com under Corporate Governance in the Investor Relations tab. The information available on, or that can be accessed through, our website is not
a part of, or incorporated by reference into, this proxy statement.

Code of Honor. The Board of
Directors has adopted a Code of Honor that is applicable to all employees of the Company, including the principal executive officer, the principal financial officer and the principal accounting officer, as well as the members of the Board of
Directors. We intend to post any amendments to or waivers from our Code of Honor (to the extent applicable to the Companys principal executive officer, principal financial officer, principal accounting officer, any other executive officer or
any director) on our website http://www.owens-minor.com under Corporate Governance in the Investor Relations tab.

Director Independence. The Board of Directors has determined that the following Board members and/or nominees are independent within the meaning of the NYSE
listing standards and the Companys Corporate Governance Guidelines: Stuart M. Essig, John W. Gerdelman, Barbara B. Hill, Lemuel E. Lewis, Martha H. Marsh, Mark F. McGettrick, Eddie N. Moore, Jr., James E. Rogers, David S. Simmons, Robert
C. Sledd and Anne Marie Whittemore. To assist it in making determinations of independence, the Board has adopted categorical standards which are included in the Companys Corporate Governance Guidelines available on our website at
http://www.owens-minor.com under Corporate Governance in the Investor Relations tab. The Board has determined that all directors and/or nominees identified as independent in this proxy statement meet these standards.

Structure and Leadership of the Board. The Board of Directors does not have a firm policy with
respect to the separation of the offices of Chairman of the Board and the Chief Executive Officer. Instead, the Board believes that it is in the best interests of the Company for this determination to be made as part of the succession planning
process when it selects a new Chief Executive Officer or when a Chairman ceases his or her service on the Board. At the time of Mr. Phipps commencement as Chief Executive Officer of the Company, the Board believed that maintaining a non-executive as Chairman of the Board was in the best interests of the Company because it preserved continuity in the Boards performance of its duties, assisted in the transition of Mr. Phipps to the
Chief Executive Officer position and management of the succession plan and provided a strong source of institutional knowledge and history of operations of the Company. In 2017, the non-executive Chairman
notified the Board that he would retire and not stand for re-election to our Board. In connection therewith, the Board evaluated the separation of the offices of the Chairman and Chief Executive Officer. As
part of that evaluation, the Board determined that, based on Mr. Phipps then 18-plus months of Board service and his performance and leadership as the Chief Executive Officer through a period of
strategic transformation and repositioning of the Company, it would be in the best interest of the Company to have Mr. Phipps serve as Chairman.

The Board believes that the combination of the Chairman and Chief Executive Officer roles also currently serves the best interests of the Company for the following reasons:



this structure results in the most effective leadership to help the Board discharge its oversight duties during a period of transformation and
repositioning of the Company;



the Chief Executive Officer is well situated to identify the key risks facing our organization and the success of its transformation and repositioning,
and ensure that these risks are brought to the attention of the Board; and



having one leader serving as both the Chairman and Chief Executive Officer provides decisive leadership while reducing the likelihood of confusion
about leadership roles and duplication of efforts, and allows the Company to speak with a unified voice.

Our Corporate Governance Guidelines also provide for the annual election of an independent lead
director by our non-management directors to, among other things, preside at Board meetings in the absence of the Chairman, preside at meetings of the independent directors, serve as the principal liaison
between the independent directors and the Chairman and Chief Executive Officer, and advise the Chairman with respect to agendas and information requirements relating to the Board and committee meetings. The Board believes that the independent lead
director enhances communications between Board members (including the Chairman) and committees as well as the overall functioning of the Boards leadership.

Majority Vote Requirement for Election of Directors. The Companys Bylaws and Corporate Governance Guidelines provide for the election of directors by majority vote in
uncontested elections. Under the Companys Corporate Governance Guidelines, with respect to director nominations, the Board will only nominate those incumbent directors who submit irrevocable resignations effective upon the failure of such
director nominee to receive the required vote for re-election and Boards acceptance of such resignation. In the event an incumbent director fails to receive a majority of the votes cast, the
Governance & Nominating Committee (or such other committee designated by the Board) will make a recommendation to the Board as to whether to accept or reject the resignation. The Board must act on the resignation, taking into account the
Governance & Nominating Committees recommendation, and publicly disclose its decision regarding the resignation, including, if applicable, its rationale for rejecting a resignation, in a press release and an appropriate disclosure
with the SEC within 90 days following certification of the election results. The Governance & Nominating Committee in making its recommendation, and the Board in making its decision, may each consider any factors or other information that
it considers appropriate and relevant.

The Boards Role in Risk Oversight. The Board of
Directors currently administers its risk oversight function through the full Board and not through a separate risk committee of the Board. However, each of the Audit Committee, the Compensation Committee and the Governance & Nominating
Committee oversees the specific financial, compensation and governance risks, respectively, relating to its functions and responsibilities and reports on these matters to the full Board. The Board performs its risk oversight function through regular
reporting by the Board committees as well as the officers and management-level personnel who supervise the day-to-day risk management activities of the Company,
including an enterprise risk steering committee comprised of senior leaders of the Company.

Risk Assessment of
Compensation Programs. With respect to our overall compensation programs, Company management reviews our compensation policies and practices each year to determine whether they create risks that are reasonably likely to
have a material adverse effect on the Company. As part of this assessment and with assistance and guidance provided by independent compensation consultant Semler Brossy Consulting Group, LLC (Semler Brossy), we reviewed the design and
features of our compensation and benefits programs and policies, potential risks that could be created by these programs and features of our programs and corporate governance policies that help to mitigate risk. Semler Brossy reviewed and discussed
the results of the assessment with the Compensation Committee. Based on this review and assessment, we believe that our compensation policies and practices do not create risks that are reasonably likely to have a material adverse effect on the
Company.

Annual Performance Evaluation.The Board conducts an annual self-evaluation to
determine whether it and its committees are functioning effectively. The Governance & Nominating Committee receives comments from all directors and reports annually to the Board with an assessment of the Boards performance. The
assessment focuses on the Boards contribution to the Company and specifically focuses on areas in which the Board or management believes that the Board can improve.

The Governance & Nominating Committee is composed of five directors, all of whom are independent. The Governance &
Nominating Committee met four times during 2017. In performing the various duties and responsibilities outlined in its charter, the Governance & Nominating Committee, among other things, received regular reports on the Companys
enterprise quality and regulatory compliance; reviewed the performance of the chief executive officer; reviewed and approved its charter and the Corporate Governance Guidelines; engaged an outside compensation firm to review and assess the
Companys director compensation program relative to comparable peer companies; and implemented the annual Board assessment process. During 2017, the Committee reviewed and recommended for Board approval several changes in the executive
management team as presented by the Chief Executive Officer and devoted time to management succession planning, including the review and approval of updates to the CEO emergency replacement plan. In anticipation of the retirement of several
directors over the next several years, the Committee devoted considerable time and attention to director succession planning, including the continued engagement of an outside consulting firm to assist in the identification and strategic recruitment
of directors possessing the qualities, character, experience and expertise that will contribute to the leadership and success of the Company in the rapidly changing healthcare industry.

The Board of Directors held 15 meetings during 2017. All directors attended at least 75% of the meetings of the Board and committees on
which they served. Our directors attend our annual meeting of shareholders unless there is compelling reason why they cannot. All of our directors, with the exception of Mr. Moore, attended our 2017 Annual Meeting of Shareholders.

Under the Companys Corporate Governance Guidelines, the independent directors meet in executive session after each regularly
scheduled Board meeting. These meetings are chaired by our lead director who is elected annually by the non-management directors following each annual meeting of shareholders. Anne Marie Whittemore currently
serves as lead director and presides over these executive sessions. As lead director, Ms. Whittemore is also invited to participate in meetings of all Board committees but is permitted to vote only in meetings of committees of which she is a
member. Shareholders and other interested parties may contact the lead director by following the procedures set forth in Communications with the Board of Directors on page 11 of this proxy statement.

COMMITTEES OF THE BOARD

The Board of Directors currently has the following committees, which the Board established to assist it with its responsibilities:

Audit Committee:Oversees (i) the integrity of the Companys financial statements, (ii) the Companys compliance with legal and regulatory
requirements, (iii) the qualification and independence of the Companys independent registered public accounting firm, (iv) the performance of the Companys independent registered public accounting firm and internal audit
functions and (v) issues involving the Companys ethical and legal compliance responsibilities. The Audit Committee has sole authority to appoint, retain, compensate, evaluate and terminate the Companys independent registered public
accounting firm. The Board of Directors has determined that each of Lemuel E. Lewis and Eddie N. Moore, Jr. is an audit committee financial expert, as defined by SEC regulations and that each member of the Audit Committee is financially
literate under NYSE listing standards. All members of the Audit Committee are independent as such term is defined under the enhanced independence standards for audit committees in the Securities Exchange Act of 1934, as amended (the Exchange
Act), and the rules thereunder as incorporated into the NYSE listing standards and under the Companys Corporate Governance Guidelines.

Compensation & Benefits Committee:Administers executive compensation programs, policies and practices. Advises the Board on salaries and
compensation of the executive officers and makes other studies and recommendations concerning compensation and compensation policies. May delegate authority for
day-to-day administration and interpretation of compensation plans to certain senior officers of the Company (other than for matters affecting executive officer
compensation and benefits). For further information on this committees processes and procedures, see Compensation Discussion and Analysis on page 33 of this proxy statement. All members of the Compensation Committee are independent
within the meaning of the enhanced NYSE listing standards and the Companys Corporate Governance Guidelines. The Compensation Committee met 6 times during 2017.

Governance & Nominating Committee:Considers and recommends nominees for election as directors and officers and nominees for each Board
committee. Reviews and recommends changes to director compensation. Reviews and evaluates the procedures, practices and policies of the Board and its members and leads the Board in its annual self-review. Oversees the governance of the Company,
including reviewing and recommending changes to the Corporate Governance Guidelines. Conducts succession planning for senior management. All members of the Governance & Nominating Committee are independent within the meaning of the NYSE
listing standards and the Companys Corporate Governance Guidelines.

Executive
Committee:Exercises limited powers of the Board when the Board is not in session. The Executive Committee did not meet during 2017.

The Governance & Nominating Committee reviews director compensation annually, and it is the responsibility of this committee to
recommend to the Board of Directors any changes in director compensation. The Board of Directors makes the final determination with respect to director compensation. The Governance & Nominating Committee has the authority under its charter
to retain outside consultants or advisors to assist it in gathering information and making decisions.

The Company uses a
combination of cash and equity compensation to attract and retain qualified candidates to serve on its Board of Directors. In setting director compensation, the Company considers the commitment of time directors must make in performing their duties,
the level of skills required by the Company of its Board members and the market competitiveness of its director compensation levels. The table below sets forth the schedule of fees paid to non-employee
directors for their annual retainer and service in various capacities on Board committees and in Board leadership roles. Employee directors do not receive any additional compensation for serving on the Board or any of its committees.

Directors may defer the receipt of all or part of their director fees under the Directors Deferred Compensation Plan.
Amounts deferred are invested in bookkeeping accounts that measure earnings and losses based on the performance of a particular investment. Directors may elect to defer their fees into the following two subaccounts: (i) an account
based upon the price of the Common Stock and (ii) an account based upon the current interest rate of the Companys fixed income fund in its 401(k) plan. Subject to certain restrictions, a director may take cash distributions from a
deferred fee account either prior to or following the termination of his or her service as a director.

The table below summarizes the actual compensation paid by the Company to
non-employee directors during the year ended December 31, 2017.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Name

Fees Earnedor
Paid

in Cash

($) (1)

StockAwards($) (1)(2)(4)

OptionAwards($) (3)

Non-EquityIncentive PlanCompensation

($)

Change
inPension ValueandNonqualifiedDeferred

Compensation

Earnings

($)

All OtherCompensation($)

Total

($)

Stuart
M. Essig

64,900

100,000









164,900

John W.
Gerdelman

70,400

100,000









170,400

Barbara
B. Hill

72,150

125,000









197,150

Lemuel
E. Lewis

87,400

100,000









187,400

Martha
H. Marsh

84,000

100,000









184,000

Mark F. McGettrick (5)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Eddie N.
Moore, Jr.

76,400

100,000









176,400

James E.
Rogers

75,000

100,000









175,000

David S.
Simmons

65,200

100,000









165,200

Robert
C. Sledd

89,000

100,000









189,000

Craig R.
Smith

44,500

N/A









44,500

Anne
Marie Whittemore

94,000

100,000









194,000

(1) Includes amounts deferred by the directors under the Directors Deferred Compensation Plan.

(2) The amounts included in the Stock Awards column are the aggregate grant date fair value of the awards
computed in accordance with the FASB ASC Topic 718.

(3) Option Awards were not granted to Directors in 2017.

(4) The Stock Award amount of $100,000 equated to 3,050 shares of Restricted Stock based on the closing stock price of $32.79 on
May 5, 2017, the date of grant. These shares vest on May 5, 2018. Upon her appointment to the Board on February 9, 2017, Ms. Hill received a Stock Award in the amount of $25,000 which equated to 696 shares of Restricted Stock
based on the closing price of $35.91 on that date. These shares vested on February 9, 2018. Mr. Smith did not receive a Stock Award during 2017.

(5) Mr. McGettrick was appointed to the Board on March 1, 2018 and therefore did not receive compensation during the year ended December 31, 2017.

The Company maintains stock ownership guidelines for its directors which provide that each director shall attain, within five years after
his or her service on the Board begins, a level of equity ownership of Common Stock having a value of at least five times the annual cash retainer fee or $150,000, whichever is higher. Each director who has served on the Board for at least five
years has achieved this ownership objective.

DIRECTOR NOMINATING PROCESS

Director Candidate Recommendations and Nominations by Shareholders. The Governance & Nominating
Committee charter provides that the Governance & Nominating Committee will consider director candidate recommendations by shareholders. Shareholders should submit any such recommendations to the Governance & Nominating Committee
through the method described under Communications with the Board of Directors below. In addition, our Bylaws provide that any shareholder of record entitled to vote for the election of directors at the applicable meeting of shareholders
may nominate directors by complying with the notice procedures set forth in the Bylaws and summarized in Shareholder Proposals on page 67 of this proxy statement.

Process for Identifying and Evaluating Director Candidates. The Governance & Nominating Committee evaluates all director candidates in accordance with the director
qualification standards and the criteria described in our Corporate Governance Guidelines. These guidelines require the Governance & Nominating Committee on an annual basis to review and evaluate the requisite skills and characteristics of
individual Board members and nominees as well as the composition of the Board as a whole. This assessment includes whether the member or candidate is independent and includes considerations of diversity, age, skills and experience in the context of
the Boards needs. The goal of the Governance & Nominating Committee is to have a Board whose membership reflects a mix of diverse skill sets, technical expertise, educational and professional backgrounds, industry experiences and
public service as well as perspectives of different genders and ethnicities. The Governance & Nominating Committee reviews its annual assessment with the Board each year and, as new member candidates are sought, attempts to maintain and
enhance the level of diverse backgrounds and viewpoints of directors constituting the Board. As part of the Boards annual self-assessment process, the Board will consider the effectiveness of its overall composition and structure as well as
its performance and functioning.

There are no differences in the manner in which the Governance & Nominating
Committee evaluates director candidates based on whether the candidate is recommended by a shareholder. The Governance & Nominating Committee did not receive any nominations from any shareholders for the 2018 Annual Meeting.

Our Bylaws provide that no director nominee can stand for election if, at the time of appointment or election, the nominee is over the
age of 72.

COMMUNICATIONS WITH THE BOARD OF DIRECTORS

The Board of Directors has approved a process for shareholders and other interested parties to send communications to the Board.
Shareholders and other interested parties can send written communications to the Board, any committee of the Board, non-management directors as a group, the lead director or any other individual director at
the following address: P.O. Box 2076, Mechanicsville, VA 23116-2076. All communications will be relayed directly to the applicable director(s).

Ten directors have been nominated for election to the Board of Directors for a one-year term
expiring at the 2019 Annual Meeting of Shareholders or until their respective successors are elected. Each nominee has agreed to serve if elected and qualified. If any nominee is not able to serve, the Board may designate a substitute or reduce the
number of directors serving on the Board. Proxies will be voted for the nominees shown below (or if not able to serve, such substitutes as may be designated by the Board). The Board has no reason to believe that any of the nominees will be unable to
serve.

Our Bylaws currently provide that the Board of Directors consists of 12 directors and the Board has approved an
amendment to our Bylaws to decrease the number of directors to 10 effective upon Messrs. Rogers and Simmons retirement from the Board effective upon the 2018 Annual Meeting. The Governance & Nominating Committee has recommended
to the Board of Directors, and the Board of Directors has approved, 10 persons as nominees for election to the Board of Directors. Proxies cannot be voted for a greater number of directors than the number of nominees named.

Information on each nominee, including the particular experience, qualifications, attributes or skills that led the Board to conclude
that he or she should serve as a director of the Company, is set forth below.

NOMINEES FOR ELECTION

Stuart M. Essig, 56, has served as
Chairman of the Board of Integra LifeSciences Holdings Corporation since 2012. From 1997 to 2012, he served as Chief Executive Officer of Integra LifeSciences, during which time he transitioned the business into a global surgical products company.
Prior to joining Integra LifeSciences, Mr. Essig was a managing director in mergers and acquisitions for Goldman Sachs Group, Inc. He also has been a Managing Partner since 2012 of Prettybrook Partners, a healthcare advisory firm. In addition
to Integra LifeSciences, he also currently serves on the boards of directors of IDEXX Laboratories, Seaspine Holdings Corporation and Breg, Inc. and formerly served on the boards of St. Jude Medical, Inc. and ZimmerBiomet. Mr. Essig has been a
director of the Company since 2013.

The Board of
Directors has nominated Mr. Essig to continue his service as a director of the Company based on his strong background and leadership experience in the medical device manufacturing industry and broad-based knowledge of the health care industry.
His insights into the medical supplies manufacturing industry, both domestic and international, bring a unique perspective to Owens & Minors Board that assists us both logistically and strategically as we seek to manage and grow our
many relationships with the manufacturing community at home and abroad.

John W. Gerdelman, 65, is Managing
Partner of River2, an investment and consulting partnership. Mr. Gerdelman was President of Long Lines Limited, a telecommunications service provider, from 2010 to 2011. Before joining Long Lines in 2010, he
co-founded Intelliden Corporation, a network solutions provider for which Mr. Gerdelman served as Executive Chairman from 2003 until it was acquired by IBM in 2010. Mr. Gerdelman has served in a
number of leadership positions for other telecommunications companies, including 15 years with MCI Communications Corporation. He currently serves on the board of directors of Brocade Communications Systems, Inc. and previously served on the boards
of Sycamore Networks, Inc., Proxim Wireless Corporation, APAC Customer Services, Inc. and McData Corporation. Mr. Gerdelman has been a director of the Company since 2010.

The Board of Directors has nominated Mr. Gerdelman to continue his service as a director of the Company based on his
unique entrepreneurial background, extensive experience in finance and accounting and expertise in telecommunications and information systems. The Board believes the Company benefits from Mr. Gerdelmans business management experience and
perspectives as Owens & Minor continues to expand systems and technology solutions used to support our own business operations as well as to provide customers with new products for supply chain management.

Barbara B. Hill, 65, has served as
an Operating Partner of NexPhase Capital, a private equity firm (formerly Moelis Capital Partners), since 2011, where she focuses on healthcare-related investments and providing strategic and operating support for NexPhases healthcare
portfolio companies. From 2006 to 2010, Ms. Hill served as Chief Executive Officer and President of FHC Health Systems and ValueOptions, Inc., a behavioral health benefits management company. Previously, Ms. Hill served as Chairman and
Chief Executive Officer of Woodhaven Health Services, an institutional pharmacy company, from 2004 to 2006, and President and a member of the board of directors of Express Scripts, a Fortune 100 pharmacy benefits management company, from 2002 to
2003. Ms. Hill also serves as a member of the board of directors of Omega Healthcare Investors, Inc., a Maryland real estate investment trust, Integra LifeSciences Holdings Corporation, a manufacturer of medical devices and implants and
formerly served on the board of St. Jude Medical, Inc. Ms. Hill has been a director of the Company since February 2017.

The Board of Directors has nominated Ms. Hill to continue her service as a director of the Company based on her extensive experience in the
healthcare industry. Ms. Hill brings deep management experience and insight both generally and specific to the healthcare industry, including unique strategic and operational experience from the managed healthcare and pharmaceutical industries.
Her unique perspective will benefit Owens & Minor as it continues to expand as a full-service partner for customers that focus on global healthcare solutions and understand the challenges faced at multiple levels within the global
healthcare marketplace.

Lemuel E. Lewis, 71, is a former Chairman of the Board of the
Federal Reserve Bank of Richmond, a position he held from 2009 until his retirement from the board on December 31, 2010. Mr. Lewis was appointed to the Board of the Federal Reserve Bank of Richmond in 2004 and served as Deputy
Chairman from 2007 to 2008, and Chairman of the Audit Committee from 2005 to 2008. He previously served as Executive Vice President and Chief Financial Officer of Landmark Communications, Inc., a privately-held media and broadcasting company,
from 2000 to 2006. He currently serves on the board of directors of Markel Corporation where he is Chairman of the Audit Committee. He also serves on the board of directors of Dollar Tree, Inc. and previously served on the board of Landmark
Communications, Inc. Mr. Lewis has been a director of the Company since 2011.

The Board of Directors has nominated Mr. Lewis to continue his service as a director of the Company based on his breadth of experience in accounting and finance through his service as Chief Financial
Officer of a private media company, as well as his service on the Board of the Federal Reserve Bank of Richmond where he chaired the Audit Committee. He also brings a wide range of differing perspectives to the Company based on his service on a
number of Virginia college and foundation boards and through his membership on the boards of two other public companies, including service on their audit committees.

Martha H. Marsh, 69, retired in
2010 as President & Chief Executive Officer of Stanford Hospital & Clinics, a position she held since 2002. She also served as the Chief Executive Officer of the University of California Davis Health System from 1999 to 2002. After
beginning her career at Arthur Andersen in 1975, she served the health care industry for more than thirty years in a variety of leadership positions, including as Senior Vice President for Professional Services and Managed Care at the University of
Pennsylvania Health System. Ms. Marsh has also served on a variety of health care boards and committees. She currently serves on the boards of directors of AMN Healthcare Services, Inc. and Edward Life Sciences and previously served on the
board of Thoratec Inc. Ms. Marsh has been a director of the Company since 2012.

The Board of Directors has nominated Ms. Marsh to continue her service as a director of the Company based on her extensive background in and knowledge of the health care industry and specifically the
health care provider marketplace with which we conduct our business. Having served in the lead management position of some of the most prestigious health care systems in the United States, she brings unique perspectives on the requirements of and
challenges faced by the health care provider industry as well as a deep understanding of the entire U.S. health care marketplace. Her broad-based background in accounting, finance, operations and management in the context of the health care industry
brings a multi-disciplinary and highly relevant point of view to our Board of Directors in assessing issues and challenges within the health care marketplace.

Mark F. McGettrick, 60, is Executive Vice President and Chief
Financial Officer of Dominion Energy Inc., a position he has held since June 2009. In addition, Mr. McGettrick also has served as Executive Vice President, Chief Financial Officer and a member of the board of directors of Dominion Energy
Midstream GP, LLC, the general partner of Dominion Energy Midstream Partners, LP, since March 2014. From January 2003 to 2009, Mr. McGetterick served as Chief Executive Officer of the companys Dominion Generation operating segment.
Mr. McGettrick joined Dominion Energy, Inc. in 1980 and during his tenure has held a variety of other management positions in distribution design, accounting, customer service and generation. He currently serves on the board of directors
of Virginia Electric and Power Company and Dominion Energy Gas Holdings, LLC, which are wholly-owned subsidiaries of Dominion Energy, Inc. Mr. McGettrick was appointed to the Board on March 1, 2018.

The Board of Directors has nominated Mr. McGettrick to
serve as a director of the Company based on his background and breadth of experience in risk management, business planning, accounting, mergers and acquisitions and financial analysis through his service as a Chief Financial Officer of a large
publicly-traded company.

Eddie N. Moore, Jr., 70, retired in
2017 as President & Chief Executive Officer of Norfolk State University. From 2011 to 2012, he served as President of St. Pauls College. He is President Emeritus of Virginia State University after serving as its President from 1993 to
2010. Prior to leading Virginia State University, Mr. Moore served as state treasurer for the Commonwealth of Virginia, heading the Department of the Treasury and serving on fifteen state boards and authorities. He also serves on the board of
directors of Universal Corporation. Mr. Moore has been a director of the Company since 2005.

The Board of Directors has nominated Mr. Moore to continue his service as a director of the Company based on his strong background in accounting and finance, which qualify him to serve as an audit
committee financial expert, and his leadership experience in managing prominent educational institutions. The Board believes that Mr. Moores experiences in the public sector bring unique perspectives and disciplines to the Boards
deliberations and decision-making processes.

P. Cody Phipps, 56, joined Owens & Minor as its
President & Chief Executive Officer effective July 1, 2015. He served as President & Chief Executive Officer of Essendant, Inc. (formerly United Stationers Inc.) from 2011 to 2015. He served as Essendants President from
2006 to 2011 and as Senior Vice President, Operations from 2003 to 2006. Previously, he was a Partner at McKinsey & Company, Inc., where he co-founded and led its Service Strategy and Operations
Initiative, which focused on driving operational improvements in complex service and logistics environments. During his tenure at McKinsey, Mr. Phipps provided consulting services to a range of corporate clients across a diverse set of
industries, including retail, manufacturing and healthcare. He formerly served on the board of directors of Con-way, Inc. and currently serves on the board of directors of R.R. Donnelley & Sons
Company. Mr. Phipps has been a director of the Company since 2015.

The Board of Directors has nominated Mr. Phipps to serve as a director of the Company based upon his unique ability as Chief Executive Officer to communicate to and inform the Board about the
Companys day-to-day operations, implementation of strategic initiatives, and industry developments. The Board believes that Mr. Phipps brings an invaluable
perspective on the Companys current operations and ongoing relationships with customers and suppliers.

Robert C. Sledd, 65, served as a Senior Economic Advisor to the
Governor of Virginia from 2010 to 2014. Since 2008, he also has served as Managing Partner of Pinnacle Ventures, LLC and Sledd Properties, LLC. From 1995 to 2008, he served as Chairman of Performance Food Group Co. (PFG), a foodservice
distribution company that he co-founded in 1987. He served as Chief Executive Officer of PFG from 1987 to 2001 and from 2004 to 2006. He also serves on the boards of directors of SCP Pool Corporation and
Universal Corporation. Mr. Sledd has been a director of the Company since 2007.

The Board of Directors has nominated Mr. Sledd to continue his service as a director of the Company based on his expertise in economic and business development policy, as well as his experience as a
former chief executive of a foodservice distribution company, including his knowledge and understanding of the specific issues and challenges faced by companies in the business of distribution and supply chain management. His experiences in
founding, growing and taking public PFG allow him to contribute to the Board a breadth of perspectives and ideas on matters of corporate management, governance and strategic growth.

Anne Marie Whittemore, 71, has been
a partner in the law firm of McGuireWoods LLP since 1977. She also serves on the board of directors of T. Rowe Price Group, Inc., formerly served on the board of Albemarle Corporation and is a former Chairman of the Board of the Federal Reserve
Bank of Richmond. Ms. Whittemore has been a director of the Company since 1991 and lead director since 2014.

The Board of Directors has nominated Ms. Whittemore to continue her service as a director of the Company based on the unique background and
perspectives she brings to the Board as an attorney whose areas of specialty include corporate governance and complex commercial and securities litigation matters. Her experience includes representation of several Fortune 100 corporations and other
companies in matters involving corporate governance and shareholder matters. Ms. Whittemore also has extensive experience as a public company director and member of both compensation and governance committees, which the Board believes
contributes to her strong leadership skills and led to her appointment in 2014 as lead director.

The Board of Directors recommends a vote FOR the election of each nominee as director.

Effective immediately following the Annual Meeting, Messrs. Rogers and Simmons terms will expire, at which time they will retire
from the Board. The Company gratefully acknowledges and thanks Mr. Rogers for his 26 years and Mr. Simmons for his four years of service and dedication to our Board.

James E. Rogers, 72, served from 2011 to 2015 as Chairman of the Board of BackOffice Associates, LLC, a private
company that provides data quality, migration and governance solutions. He served as President of SCI Investors Inc, a private equity investment firm, from 1993 until his retirement in 2011. He also serves on the board of directors of NewMarket
Corporation and formerly served on the boards of Caraustar Industries, Inc., Wellman, Inc., Chesapeake Corp. and Cadmus Communications, Inc. Mr. Rogers has been a director of the Company since 1991 and has demonstrated significant leadership
and communication skills in his service as the Companys independent lead director for more than 10 years until 2014. Mr. Rogers will retire immediately following the 2018 Annual Meeting.

David S. Simmons, 53, has served as Chairman & Chief Executive Officer
of Pharmaceutical Product Development, LLC, a global biopharmaceutical research organization, since 2012. From 2001 to 2012, Mr. Simmons served in a variety of management positions with Pfizer, Inc., including as President and General Manager
of the Emerging Markets and Established Products Business Units, Regional President of the Eastern Europe Pharmaceutical Division, President of the Pharmaceutical Division in Greece and Vice President of Marketing in Canada. Mr. Simmons has
been a director of the Company since 2013 and will retire immediately following the 2018 Annual Meeting.

The Company currently has in effect the 2015 Stock Incentive Plan (the 2015 Plan). The 2015
Plan permits the grant of options, stock appreciation rights, stock awards, stock units and incentive awards. On February 8, 2018, our Board of Directors adopted the Owens & Minor, Inc. 2018 Stock Incentive Plan (the 2018
Plan), subject to the approval of shareholders. Like the 2015 Plan, the 2018 Plan authorizes the grant of options, stock appreciation rights, stock awards, stock units and incentive awards. If the shareholders approve the 2018 Plan, no
additional awards will be granted under the 2015 Plan after the date of shareholder approval of the 2018 Plan. The closing price of the Companys Common Stock on March 1, 2018 was $16.11 per share.

Our Board of Directors believes that the 2015 Plan has benefited, and the 2018 Plan will benefit, the Company, by (i) assisting in
recruiting and retaining the services of teammates and non-employee directors with high ability and initiative, (ii) providing greater incentives for teammates and
non-employee directors who provide valuable services to the Company and its subsidiaries and affiliates and (iii) associating the interests of these persons with those of the Company and its shareholders.

Key features of the 2018 Plan, which contains provisions considered best practices for compensation and governance purposes,
include:



The 2018 Plan generally will be administered by our Compensation Committee which consists entirely of independent
non-employee directors.



The 2018 Plan sets reasonable limits as to the awards any teammate, or non-employee director may receive in any
calendar year.



All stock options and stock appreciation rights must have an exercise price that is not less than the fair market value of the underlying stock on the
grant date.



The maximum number of shares of our Common Stock that will be made available under the 2018 Plan is the sum of (i) 3,600,000 shares, less the
number of shares of our Common Stock subject to awards granted under the 2015 Plan after March 1, 2018,plus (ii) the number of shares of our Common Stock subject to awards granted under the 2015 Plan that become available after
March 1, 2018 because of the expiration, cancellation or forfeiture of the award without the issuance of the underlying shares. Between January 1, 2018 and March 1, 2018, awards representing 705,882 shares of Common Stock were granted
under the 2015 Plan. This does not include awards to be granted in connection with our acquisition of Halyard Health S&IP, which we estimate will represent approximately 364,540 shares (based on a Common Stock price of $16.11 per share). We
currently expect this acquisition to close early in the second quarter of 2018.



Shares of Common Stock not issued as the result of a net settlement of options, stock appreciation rights, stock awards, stock units and incentive
awards, or tendered or withheld to pay the exercise price, purchase price or withholding taxes relating to options, stock appreciation rights, stock awards, stock units and incentive stock awards, shall not again be made available for issuance as
awards under the 2018 Plan.



All awards granted under the 2018 Plan will be subject to a one-year minimum vesting period, provided that
(i) up to 5% of the shares authorized for issuance under the 2018 Plan (subject to adjustments) may provide for vesting of awards in less than one year and (ii) awards granted to non-employee
directors may vest earlier than one year upon the annual meeting of the Companys shareholders that occurs in the year immediately following the year of grant so long as the awards vest as of a date that is not earlier than two weeks prior to
the anniversary date of the immediately preceding years annual shareholders meeting.



In connection with a change in control, vesting of time-based awards will only be accelerated if the time-based
awards are not assumed or converted into substitute awards following the change in control and vesting of performance-based awards shall only be accelerated to the extent of actual

achievement of the performance conditions as of the date of the change in control or on a prorated basis for time elapsed in ongoing performance period(s) through the date of the change in
control, whichever the Committee determines appropriate, if the performance-based awards are not assumed or converted into substitute awards following the change in control. Otherwise, vesting of an award may only be accelerated in connection with a
termination of service (including but not limited to death, disability, retirement or involuntary termination) or if the award is outstanding for at least one year, provided that up to 5% of the shares authorized for issuance under the 2018 Plan may
be issued pursuant to awards without regard to any such restriction on accelerated vesting.



The 2018 Plan does not include any reload feature which would provide for an automatic grant of additional awards or any evergreen share
replenishment features which would provide for an automatic increase in the number of shares available for issuance.



The 2018 Plan prohibits the repricing of outstanding stock options, stock appreciation rights and other stock awards in the nature of purchase rights,
whether by amending an existing award or by substituting a new award at a lower price, without shareholder approval. The 2018 Plan also prohibits the payment of cash, awards or other securities in exchange for out-of-the-money awards, without shareholder approval.



Awards granted under the 2018 Plan are subject to the Companys Recoupment Policy (which is described on page 52 of this proxy statement).



There is not a liberal change in control definition in the 2018 Plan. A change in control does not occur on announcement or commencement of a tender
offer or a potential takeover or on shareholder approval of a merger or other transaction.



Any material amendments to the 2018 Plan require shareholder approval.



No dividends or dividend equivalents may be granted in connection with options, stock appreciation rights or other awards in the nature of purchase
rights. No dividends or dividend equivalents may be paid in connection with a stock award or stock unit unless and until the award is no longer subject to forfeiture conditions, and any such dividends or dividend equivalents will either be
(i) deemed reinvested in additional awards which remain subject to the same forfeiture and other conditions applicable to the award to which such dividends or dividend equivalents related or (iii) accumulated (without interest) and become
payable only at the time and to the extent the related award becomes nonforfeitable and/or payable. No dividends may be paid with respect to an award that is forfeited.



The 2018 Plan does not provide for tax gross-ups of any kind.

A summary of the principal features of the 2018 Plan is included below. However, every aspect of the 2018 Plan is not addressed in this
summary and shareholders are encouraged to read the full text of the 2018 Plan which is attached to this proxy statement as Annex A. We have no current plans, proposals or arrangements, written
or otherwise, to grant any specific awards under the 2015 Plan that have not been granted as of March 1, 2018or under the 2018 Plan, except in connection with the closing of our acquisition of Halyard Health S&IP or as provided for
under our Board of Directors compensation plan (as described on pages 18 and 9 respectively of this proxy statement).

Reasons for the 2018
Plan and Recommendation of the Board of Directors

As described in more detail in this proxy statement under
Executive CompensationCompensation Disclosure and Analysis, we believe our compensation programs are structured to attract, retain and motivate our teammates and non-employee directors. Our
Board of Directors believes that equity incentive awards play a key role in these programs as they help align the interests of teammates and non-employee directors with those of our shareholders. As of
March 1, 2018, there were (1) 61,488,172 shares of our Common Stock outstanding, (2) 1,532,907 full value shares outstanding which include outstanding Performance Shares at target but there are no outstanding stock options or stock appreciation
rights, and (3) only 773,638 shares available for grant under the 2015 Plan, which amount will be further reduced by the grant of awards representing an estimated 364,540 additional shares of Common Stock in connection with the Halyard Health
S&IP acquisition.

Historical Burn Rate; Potential Economic Dilution Analysis. We are committed to
managing the use of our equity incentives prudently to balance the benefits equity compensation brings to our compensation programs against the dilution it causes our shareholders. As part of our analysis when considering the number of shares to be
reserved under the 2018 Plan, we considered the 2015 Plans burn rate, calculated as the number of shares subject to equity awards granted under the 2015 Plan, divided by the weighted average number of shares outstanding for that
period. Our average burn rate for the three years ending December 31, 2017 was 3.73%. The total potential dilution resulting from issuing all shares authorized under our equity plans as of March 1, 2018 would be approximately 3.8%. We believe
that our burn rate and potential dilution amounts are reasonable for our industry and market conditions. Since the 2015 Plan was adopted, we have sought to provide equity compensation to our teammates and
non-employee directors who we believe are important to our organization in furthering our business strategy. In addition, since that time we have made multiple leadership appointments and promotions to advance
our strategy. We made equity grants from the 2015 Plan in connection with each of these new hires and promotions. We believe these new hires and promotions are key to the development and strengthening of the management team with the experience and
talent necessary to further implement our transformation. Additionally, we have made two significant acquisitions in 2017 and 2018, Byram Healthcare and Halyard Health S&IP, to accelerate our transformation and have issued awards under our 2015
Plan prior to March 1, 2018 representing 63,501 shares of Common Stock to teammates who have joined us from Byram Healthcare and expect to issue awards representing an additional 364,540 shares of Common Stock to teammates who will join us from
Halyard Health S&IP.

Expected Duration. We expect that the shares available under the 2018 Plan for future awards,
if the 2018 Plan is approved by our shareholders, will be sufficient for currently-anticipated awards for the next three - four years. Expectations regarding future
share usage could be impacted by a number of factors such as hiring and promotion activity at the executive level; the rate at which shares are returned to the 2018 Plan reserve upon awards expiration, forfeiture or cash settlement; the future
performance of our stock price; factors involved in acquiring other companies; and other factors. While we believe that the assumptions we used are reasonable, future share usage may differ from current expectations.

For the foregoing reasons, our Board of Directors recommends that our shareholders approve the 2018 Plan.

Administration of the 2018 Plan

The 2018 Plan is generally administered by the Compensation Committee. The Compensation Committee approves all terms of awards to teammates under the 2018 Plan. The Compensation Committee also approves
the teammates who will receive grants under the 2018 Plan, determines the type of award that will be granted and approves the number of shares of Common Stock subject to the grant. The Governance & Nominating Committee of the Board of
Directors administers the 2018 Plan in the case of any award that is made to a member of the Board who is not also a teammate of the Company or an affiliate. References in this summary to the Compensation Committee include, with respect
to awards made to non-employee directors, the Governance & Nominating Committee.

Participation in 2018 Plan

Because awards under the 2018 Plan are made at the Compensation Committees discretion, we are unable to determine who will be selected to receive awards or the type, size or terms of the awards that
may be granted. For the same reason, we are unable to determine the awards that would have been granted last year if the 2018 Plan had been in effect. However, outstanding awards previously granted under the 2015 Plan are reported herein. See
Grants of Plan Based Awards Table on page 56 and Outstanding Equity Awards at Fiscal Year-End Table on page 58 of this proxy statement.

Any teammate, consultant or non-employee director of the Company or any affiliate who, in the
judgment of the Compensation Committee, has contributed significantly or can be expected to contribute significantly to

the performance of the Company and/or its affiliates may receive an award under the 2018 Plan. The Company currently has approximately 8,600 teammates (including approximately 10 teammates who
are officers), and the Company currently has 11 non-employee directors. In fiscal 2017 the Company made awards to 301 participants, which included nine executive officers and our 10 non-employee directors. The Compensation Committee has the complete discretion, as provided in the 2018 Plan, to select eligible teammates, consultants and/or non-employee
directors to receive awards under the 2018 Plan and to determine for each teammate, consultant or non-employee director the nature of the award and the terms and conditions of each award.

The basis for participation in the 2018 Plan is that the Compensation Committee has determined that such participation will further the
2018 Plans purposes. In exercising its discretion, the Compensation Committee will consider the recommendations of management and the purposes of the 2018 Plan, which include the recruiting and retaining of teammates and non-employee directors with high ability and initiative, providing greater incentives for teammates and non-employee directors who provide valuable services to the Company and
its subsidiaries and affiliates and associating the interests of these persons with those of the Company and its shareholders. For a description of the basis of participation for our executive officers and
non-employee directors during fiscal 2017, see Compensation Discussion and Analysis beginning on pages 33 through 53 of the proxy statement and Director Compensation on page 9 of the
proxy statement.

The 2018 Plan includes reasonable limits on the benefits that any participant may receive for any calendar
year. No teammate may be granted, in any calendar year, (i) options, stock appreciation rights or other purchase rights for more than 2,000,000 shares of our Common Stock, (ii) stock awards or stock units for more than 1,000,000 shares of
our Common Stock or (iii) incentive awards exceeding $10,000,000. The foregoing limitations can be multiplied by two for awards granted to teammates during the calendar year in which the teammate first commences employment or other service. The
2018 Plan also provides that in any calendar year a non-employee director may not be granted awards during any single calendar year in respect of the non-employee
directors service as a member of the board that, taken together with any cash fees paid to the non-employee director, exceeds $750,000 in total value (calculating the value of any such awards based on
the grant date fair value of such awards for financial accounting purposes). The Compensation Committee may, however, make exceptions to the foregoing limit (up to twice such limit) for a non-executive chair
of the Board of Directors or, in extraordinary circumstances, for other individual non-employee directors, as the Compensation Committee may determine, provided that the
non-employee director receiving such awards may not participate in the decision to make such awards.

Share Authorization

The
maximum aggregate number of shares of Common Stock that may be issued under the 2018 Plan is the sum of (i) 3,600,000 shares, less the number of shares of our Common Stock subject to awards granted under the 2015 Plan afterMarch 1,
2018, plus (ii) the number of shares of our Common Stock that are subject to awards granted under the 2015 Plan that become available after March 1, 2018 because of the expiration, cancellation or forfeiture of the award without the
issuance of the underlying shares. In connection with stock splits, stock dividends, recapitalizations and certain other events, the Board will make adjustments that it deems appropriate in the aggregate number of shares of Common Stock that may be
issued under the 2018 Plan, the terms of outstanding awards and the per individual grant limitations.

Except as described
herein, each share of Common Stock issued in connection with an award granted under the 2018 Plan will reduce the total number of shares of Common Stock available for issuance under the 2018 Plan by one. If any options, stock appreciation rights,
stock awards, stock units or other awards terminate, expire or are canceled, forfeited, exchanged or surrendered without having been exercised or paid or without issuance of the underlying shares, the Common Stock subject to such awards, to the
extent of the termination, expiration, cancellation, forfeiture, surrender or cash settlement, will again be available for awards under the 2018 Plan. Any shares of Common Stock that are tendered or withheld from the settlement of an award to
satisfy the grant or exercise price or to satisfy a tax withholding obligation under an award will not be available for future awards to

be granted under the 2018 Plan. If Common Stock is issued in settlement of a stock appreciation right, the number of shares available for future awards will be reduced by the number of shares for
which the stock appreciation right was exercised rather than the number of shares issued. Shares of Common Stock that may be issued under the 2018 Plan may not be increased through the Companys purchase of shares of Common Stock on the open
market with the proceeds obtained from the exercise of options or other purchase rights granted under the 2018 Plan.

Awards

The Compensation Committee will determine the eligible individuals who will receive awards under the 2018 Plan and the
Compensation Committee will specify the type of award that is made and will prescribe the terms and conditions that govern each award. The 2018 Plan generally provides that no award will become fully exercisable or entirely vested before the first
anniversary of the date of grant of the award, provided that (i) awards may be granted without regard to this minimum vesting requirement with respect to a maximum of 5% of the shares of Common Stock authorized for issuance under the 2018 Plan
and (ii) awards may be granted without regard to the minimum vesting requirement to non-employee directors as described above. Notwithstanding the preceding sentence, the Compensation Committee may
accelerate the exercisability or vesting of awards (i) in connection with a termination of employment or other service (including without limitation on death, disability, retirement or involuntary termination) or (ii) if the award has been
outstanding for at least one year, and up to 5% of the shares of Common Stock authorized for issuance under the 2018 Plan may be issued without regard to any such restrictions on accelerated vesting of awards.

Options. The 2018 Plan authorizes the Compensation Committee to grant incentive stock options (under
Section 421 of the Internal Revenue Code) and options that do not qualify as incentive stock options. The exercise price of each option will be determined by the Compensation Committee, provided that the price cannot be less than 100% of the
fair market value of the Common Stock on the date on which the option is granted (or 110% of the shares fair market value on the grant date in the case of an incentive stock option to an individual who is a ten percent shareholder
under Sections 422 and 424 of the Internal Revenue Code). Except in the event of stock splits, stock dividends and other changes in our capitalization, unless approved by shareholders, the exercise price of an outstanding option cannot be
reduced and no payment can be made to cancel an option if the exercise price exceeds the shares fair market value on the date of cancellation.

The exercise price for any option is generally payable (i) in cash, (ii) in a cash equivalent acceptable to the Compensation Committee, or (iii) by the surrender of Common Stock (including
Common Stock otherwise issuable upon exercise of the option) (or attestation of ownership of Common Stock) with an aggregate fair market value on the date on which the option is exercised equal to the exercise price for the number of shares being
purchased.

The term of an option cannot exceed 10 years from the date of grant (or five years in the case of an incentive
share option granted to a ten percent shareholder). The Compensation Committee may grant options that have a term less than the maximum term permitted under the 2018 Plan. The 2018 Plan provides for the automatic exercise of options if
(a) the participant remains in the continuous employ or service of the Company from the date of grant until the stated expiration date of the option and (b) the fair market value of the shares subject to the option exceeds the exercise
price. In that event, if not exercised by the participant, the option will be exercised on the stated expiration date and the participant will be issued shares of Common Stock that have a fair market value equal to the excess of the aggregate number
of shares subject to the exercised portion of the option over the number of shares whose fair market value equals the aggregate exercise price of the option and applicable tax withholdings.

No dividends may be paid with respect to an option.

Stock Awards. The 2018 Plan also provides for the grant of stock awards. A stock award is an award of Common Stock that will be subject to restrictions on transferability and
such other restrictions as the

Compensation Committee determines on the date of grant and consistent with the terms of the 2018 Plan, including the vesting requirements described above. The vesting requirements or restrictions
may be stated with reference to one or more performance objectives, including objectives stated with respect to performance goals as described below under Performance Objectives. The restrictions, if any, may lapse over a
specified period of time or through the satisfaction of conditions, in installments or otherwise, as the Compensation Committee may determine.

A participant who receives a stock award will have all of the rights of a shareholder as to those shares, including, without limitation, the right to vote and the right to receive dividends or
distributions on the shares; provided, however, that the 2018 Plan provides that dividends payable on a stock award shall either be deemed reinvested in additional stock awards, which shall remain subject to the same forfeiture and transfer
conditions applicable to the stock award with respect to which such dividends related, or accumulated and paid in cash, without interest, if and at the time the related stock award is no longer subject to forfeiture and transfer conditions. During
the period, if any, when stock awards are non-transferable or forfeitable, (i) a participant is prohibited from selling, transferring, pledging, exchanging, hypothecating or otherwise disposing of his or
her stock award shares, (ii) the company will retain custody of the certificates and (iii) a participant must deliver a share power to the Company for each stock award. No dividends may be paid with respect to a stock award that is
forfeited.

Stock Appreciation Rights. The 2018 Plan authorizes the Compensation Committee to
grant stock appreciation rights that provide the recipient with the right to receive, upon exercise of the stock appreciation right, cash, Common Stock or a combination of the two. The amount that the recipient will receive upon exercise of the
stock appreciation right generally will equal the excess of the fair market value of the Common Stock on the date of exercise over the shares fair market value on the date of grant (the initial value). Stock appreciation rights
will become exercisable in accordance with terms prescribed by the Compensation Committee and consistent with the terms of the 2018 Plan, including the vesting requirements described above. Stock appreciation rights may be granted in tandem with an
option grant or independently from an option grant. The term of a stock appreciation right cannot exceed ten years from the date of grant or five years in the case of a share appreciation right granted in tandem with an incentive stock option
awarded to a ten percent shareholder. The Compensation Committee may grant stock appreciation rights that have a term less than such maximum terms. The 2018 Plan provides for the automatic exercise of a stock appreciation right if
(a) the participant remains in the continuous employ or service from the date of grant until the stated expiration date of the stock appreciation right and (b) the fair market value of the shares subject to the stock appreciation right
exceeds the initial value per share. In that event, if not exercised by the participant, the stock appreciation right will be exercised on the stated expiration date and the participant will receive the amount payable for exercises on that date
(subject to applicable withholdings).

Except in the case of stock splits, stock dividends and other changes in our
capitalization, the initial value of an outstanding stock appreciation right cannot be reduced without the approval of shareholders. In addition, the 2018 Plan provides that no payment may be made on account of the cancellation of a stock
appreciation right if the initial value exceeds the fair market value of a share of Common Stock.

No dividends may be paid
with respect to any stock appreciation rights.

Stock Units. The 2018 Plan also authorizes the
Compensation Committee to grant awards of stock units. Stock units represent the participants right to receive an amount, based on the value of the Common Stock, if the requirements established by the Compensation Committee are satisfied.
Consistent with the terms of the 2018 Plan, including the vesting requirements described above, the Compensation Committee will determine the applicable performance period, the performance goals and such other conditions that apply to the stock unit
award. Performance goals may be stated with respect to the performance criteria described below under Performance Objectives or such other criteria determined by the Compensation Committee. If the performance goals and other requirements
are met, stock units will be paid in cash, Common Stock or a combination thereof.

Incentive Awards. The 2018 Plan also permits the grant of
incentive awards. An incentive award is an opportunity to earn a payment upon the terms and conditions prescribed by the Compensation Committee. The terms and conditions may provide that the incentive award will be earned only if the
participants employment continues for a specified period or only to the extent that the participant, the Company or an affiliate achieves objectives measured over a period of at least one year. The objectives may be stated with reference to
one or more of the performance criteria described below under Performance Objectives or such other criteria determined by the Compensation Committee. If an incentive award is earned, the amount payable will be paid in cash, Common Stock
or a combination thereof. No dividends may be paid in respect of an incentive award.

Change in Control

Unless an outstanding award is assumed or otherwise continued after a change in control, upon a change in control and cash-out of the award, (i) each option and stock appreciation right shall be fully exercisable thereafter, (ii) each stock award will become transferable and nonforfeitable, (iii) each stock unit
award shall be earned in its entirety and converted into a transferable and nonforfeitable stock award, and (iv) each incentive award shall be earned, in whole or in part, in accordance with the terms of the applicable award agreement, except
that (i) each performance-based option and stock appreciation right shall be exercisable, (ii) each performance-based stock award will become transferable and nonforfeitable, (iii) each performance-based stock unit award will be
earned and converted into a transferable and nonforfeitable stock award, and (iv) each performance-based incentive award shall be earned only to the extent of actual performance through the date of the change in control or pro rata based on the
elapsed portion of the performance period as of the date of the change in control, whichever the Committee determines appropriate.

In the event of a change in control, the Compensation Committee, in its discretion and without the need for a participants consent, may provide that an outstanding option, stock appreciation right,
stock award, stock unit award or incentive award shall be assumed by, or a substitute award granted by, the surviving entity in the change in control. Such assumed or substituted award shall be of the same type of award as the original option, stock
appreciation right, stock award, stock unit award or incentive award being assumed or substituted.

Unless an outstanding
award is to be assumed or otherwise continued after the change in control, the Compensation Committee, in its discretion and without the need of a participants consent, may provide that (i) each option and stock appreciation right that is
or will be exercisable on the date of the change in control, (ii) each stock award that is or will become transferable and nonforfeitable, (iii) each stock unit award that is or will be earned and convertible into a transferable and
nonforfeitable stock award and (iv) each inventive award that is or will be earned shall be cancelled in exchange for a payment. The payment may be in cash, shares of Common Stock or other securities or consideration received by Company
shareholders in the change in control transaction. The amount of the payment will be equal to (i) the amount by which the price per share received by the shareholder in the transaction exceeds the exercise price of the option or initial value
of the stock appreciation right, (ii) the price per share received by the shareholders in the transaction for each share subject to a stock award or stock unit or (iii) the amount earned under the incentive award. Notwithstanding the
foregoing, however, awards that are not vested, non-forfeitable or payable as of the change in control will be cancelled without any payment therefor.

A change of control under the 2018 Plan generally occurs if:



a person, entity or affiliated group (with certain exceptions) acquires, in a transaction or series of transactions, at least 30% of our combined
voting power;



we merge with another entity unless (i) the voting securities of the Company immediately prior to the merger continue to represent more than 50%
of the combined voting power of the securities in the merged entity or its parent or (ii) the merger is effected to implement a recapitalization transaction in which no person acquires more than 30% of our combined voting power;



there is consummated an agreement for the sale or disposition of all or substantially all of our assets;

during any period of twelve (12) consecutive months, individuals who, at the beginning of such period, constitute our Board, together with any new
directors whose nomination or election was approved by a majority of the directors then so in office (other than individuals who become directors in connection with certain transactions or election contests), cease for any reason to constitute a
majority of our Board.

The Internal Revenue Code has special rules that apply to parachute
payments, i.e., compensation that is payable on account of a change in control. If the parachute payments exceed a safe harbor amount prescribed by the Internal Revenue Code, then the recipient is liable for a 20% excise tax on a
portion of the parachute payments, and the Company is not allowed to claim a federal income tax deduction for a portion of the parachute payments.

The 2018 Plan provides for a reduction in benefits if the benefits of awards, either alone or together with parachute payments under other plans and agreements, exceed the safe harbor amount. In that
event, the participants total parachute payments will be reduced to the safe harbor amount, i.e., the maximum amount that may be paid without an excise tax liability or loss of deduction. However, the benefits will not be reduced, and
the participant will receive all of the parachute payments, if the participant will receive a greater after-tax benefit, taking into account the excise tax payable by the participant, by receiving all of the
parachute payments. The 2018 Plan provides that these provisions do not apply to a participant who, under an agreement with the Company or the terms of another plan is not permitted to receive parachute payments in excess of the safe harbor
amount.

Performance Objectives

The 2018 Plan also identifies performance criteria that may be used to establish performance goals that will determine whether an award becomes vested or is earned. The Compensation Committee may
prescribe that an award will become vested or be earned upon the attainment of one or more performance goals or objectives, including but not limited to: (i) gross, operating or net earnings before or after taxes; (ii) return on equity;
(iii) return on capital; (iv) return on sales; (v) return on assets or net assets; (vi) earnings per share; (vii) cash flow per share; (viii) book value per share; (ix) earnings growth; (x) sales or sales
growth; (xi) volume growth; (xii) cash flow (as defined by the Compensation Committee); (xiii) Fair Market Value; (xiv) total shareholder return; (xv) market share; (xvi) productivity; (xvii) level of expenses;
(xviii) quality; (xix) safety; (xx) customer satisfaction; (xxi) total economic value added; (xxii) earnings before interest, taxes, depreciation and amortization; and (xxiii) revenues or revenue growth.

A performance goal or objective may be stated with respect to the Company, a subsidiary or a business unit and also may be stated with
respect to one or more of these criteria or may be expressed on an absolute basis or relative to the performance of one or more similarly situated companies or a published index. In establishing a performance goal or objective, the Compensation
Committee may exclude any or all special, unusual or extraordinary items as determined under generally accepted accounting principles, including the charges or costs associated with restructurings of the Company, discontinued operations, other
unusual or non-recurring items and the cumulative effects of accounting changes. The Compensation Committee may also adjust performance goals or objectives, including to reflect the impact of unusual or non-recurring events affecting the Company and for changes in applicable tax laws and accounting principles.

Section 162(m) Transition Rule

If and to the extent that the Compensation Committee grants an award under the 2018 Plan in substitution for an award intended to constitute qualified performance-based compensation under
Section 162(m) of the Internal Revenue Code, as in effect prior to the enactment of the Tax Cuts and Jobs Act of 2017, or pursuant to a

binding contract in effect as of November 2, 2017 and intended to constitute qualified performance-based compensation under the special transition rule under Section 162(m)
then such award shall be (i) subject to such terms and conditions as are required for the award to continue to qualify under the transition rule for qualified performance-based compensation under Section 162(m) under the Tax
Cuts and Jobs Act of 2017, as the Compensation Committee shall determine, (ii) the award will be administered by a sub-committee of the Compensation Committee which is comprised of two or more members
that qualify as outside directors under Section 162(m) prior to the enactment of the Tax Cuts and Jobs Act of 2017, and (iii) none of the provisions of the 2018 Plan shall apply to such award to the extent such provisions would
result in the award no longer qualifying under the transition rule for qualified performance-based compensation under Section 162(m) prior to the Tax Cuts and Jobs Act of 2017.

Return of Awards; Repayment

The 2018 Plan provides that all awards, and all payments under awards, are subject to any policy that the Company adopts requiring the return or repayment of compensation and/or benefits, i.e., a
claw-back or compensation recoupment policy. To the extent required by any such policy as in effect on the date that the award is granted, the date the option or stock appreciation right was exercised, the date of payment or the date the award
became vested or earned, a participant will be required to return any award (if not previously exercised or settled) and any payment previously made or proceeds received with respect to any award (if the award has vested or been settled).

Amendment; Termination

The 2018 Plan may be amended or terminated at any time by the Board of Directors; provided that no amendment may adversely impair the rights of participants under outstanding awards. Our shareholders must
approve any amendment if such approval is required under applicable law or stock exchange requirements. Our shareholders also must approve any amendment that materially increases the benefits accruing to participants under the 2018 Plan, materially
increases the aggregate number of shares of Common Stock that may be issued under the 2018 Plan (other than adjustments to reflect stock dividends, stock splits and other changes in capitalization) or materially modifies the requirements as to
eligibility for participation in the 2018 Plan. In addition, except in connection with adjustments to reflect stock dividends, stock splits and other changes in capitalization, the exercise price of an option, the purchase price of an award or the
initial value of a stock appreciation right may not be reduced and no action that would constitute a re-pricing of such awards may be taken without the approval of shareholders.

The 2018 Plan provides that, unless terminated sooner by the Board or extended with shareholder approval, no awards may be made under the
2018 Plan after February 7, 2028.

Deferral of Awards

The Compensation Committee may permit a participant to defer, or if and to the extent specified in an award agreement require the participant to defer, receipt of the payment of cash or the delivery of
shares of Common Stock that would otherwise be due by virtue of the lapse or waiver of restrictions with respect to awards, the satisfaction of any requirements or goals with respect to awards, the lapse or waiver of the deferral period for awards,
or the lapse or waiver of restrictions with respect to awards. If such deferral is permitted, the Compensation Committee will establish rules and procedures for making such deferral elections and for the payment of such deferrals which will be
intended to conform in form and substance with applicable regulations promulgated under Section 409A of the Internal Revenue Code. There are no assurances, however, that a participant will not be subjected to tax penalties under
Section 409A with respect to any awards or such deferrals.

Awards do not confer upon any individual any right to continue in the employ or service of the Company or any affiliate.

U.S. Federal Income Tax Consequences

The grant of an option or stock
appreciation right will create no tax consequences for the participant or the Company at the time of the grant. A participant will have no taxable income upon exercise of an incentive stock option except that a participant must recognize income
equal to the fair market value of the shares acquired minus the exercise price for alternative minimum tax purposes. Upon exercise of an option (other than an incentive stock option) or a stock appreciation right, a participant generally must
recognize ordinary income equal to the fair market value of the shares and/or the amount of cash acquired minus the exercise price or initial value. Upon a disposition of shares acquired by exercise of an incentive stock option on or before the
earlier of the second anniversary of the grant of such incentive stock option or the first anniversary of the exercise of such option, the participant generally must recognize ordinary income equal to the lesser of (1) the fair market value of
the shares at the date of exercise minus the exercise price, or (2) the amount realized upon the disposition of the incentive stock option shares minus the exercise price. Otherwise, a participants disposition of shares acquired upon the
exercise of an option (including an incentive stock option for which the incentive stock award option holding periods are met) generally will result in only capital gain or loss. Other awards under the 2018 Plan, including stock awards, stock units
and incentive awards, will generally result in ordinary income to the participant equal to the cash or the fair market value of the shares received (minus the amount, if any, paid by the participant for such shares) at the time such cash or shares
are received by the participant or, if later, the time that the substantial risk of forfeiture of such shares lapses.

The
Company generally will be entitled to claim a tax deduction with respect to an award granted under the 2018 Plan when the participant recognizes ordinary income with respect to the award in an amount equal to the ordinary income that is recognized
by the participant. The Company will not be entitled to claim any tax deduction of any amount recognized by a participant as capital gains.

The Company will be permitted to withhold from any award granted under the 2018 Plan any required withholding taxes. Payment of withholding taxes may be made through one or more of the following means:
payment in cash (including personal check or wire transfer), or, with the approval of the Committee, by delivering shares previously owned by the grantee or by delivery of shares acquired or to be acquired under the award.

Section 83(b) of the Internal Revenue Code.A participant may elect under
Section 83(b) of the Internal Revenue Code to be taxed at the time of grant of a stock award on the fair market value of the shares at that time rather than to be taxed when the risk of forfeiture lapses on the stock, and the Company will have
a deduction available at the same time and in the same amount as the participant recognized income. If a participant files an election under Section 83(b) and the participant subsequently forfeits the restricted shares, he or she would not be
entitled to any tax deduction, including as a capital loss, for the value of the shares on which he or she previously paid tax. Except as discussed below, the Company generally will be entitled to a tax deduction at the time and equal to the amount
recognized as ordinary income by the participant in connection with an option, stock appreciation right, or other award, but will be entitled to no tax deduction relating to amounts that represent a capital gain to a participant, Thus, the Company
will not be entitled to any tax deduction with respect to an incentive stock option if the participant holds the shares for the incentive stock option holding periods.

The Board of Directors recommends that you vote FOR approval of the Owens & Minor, Inc. 2018 Stock Incentive Plan.

The Audit Committee (with confirmation of the Board) has selected KPMG LLP to serve as the Companys
independent registered public accounting firm for the year ending December 31, 2018 and has directed that management submit such appointment of KPMG LLP for ratification by the shareholders at the annual meeting. Representatives of KPMG LLP
will be present at the annual meeting to answer questions and to make a statement, if they desire to do so.

Under the
Sarbanes-Oxley Act of 2002 and the rules of the SEC promulgated thereunder, the Audit Committee is solely responsible for the appointment, compensation and oversight of the work of the Companys independent registered public accounting firm.
Shareholder ratification of this appointment is not required by the Companys Bylaws or otherwise. If shareholders fail to ratify the appointment, the Audit Committee will take such failure into consideration in future years. If shareholders
ratify the appointment, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if it is determined that such a change would be in the best interests
of the Company.

Prior to selecting KPMG LLP for fiscal 2018, the Audit Committee evaluated KPMGs performance with
respect to fiscal 2017. In conducting this annual evaluation, the Audit Committee considered managements assessment of KPMGs performance in areas such as (i) independence, (ii) the quality and the efficiency of the services
provided, including audit planning and coordination, (iii) industry knowledge and (iv) the quality of communications, including KPMG staff accessibility and keeping management apprised of issues. The Audit Committee also considered
KPMGs tenure, the impact on the Company of changing auditors and the reasonableness of KPMGs billable rates. The Audit Committee is responsible for the audit fee negotiations associated with the retention of KPMG LLP. In order to
assure continuing auditor independence, the Audit Committee periodically considers whether there should be a regular rotation of the independent registered accounting firm. Further, in conjunction with the rotation of the auditing firms lead
engagement partner every five years, the Audit Committee and its chairperson will continue to be directly involved in the selection of KPMG LLPs new lead engagement partner. The members of the Audit Committee and the Board believe that
the continued retention of KPMG LLP to serve as our independent external auditor is in the best interests of us and our stockholders.

The Board of Directors recommends a vote FOR the ratification of the appointment of KPMG LLP to serve as the Companys independent registered
public accounting firm for the year ending December 31, 2018.

FEES PAID TO INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM

For each of the years ended December 31, 2017 and 2016, KPMG LLP billed the Company the fees
set forth below in connection with professional services rendered by that firm to the Company:

Year 2017

Year 2016

Audit Fees

$

2,110,500

$

1,956,000

Audit-Related Fees

23,500

32,000

Tax Fees

264,000

102,000

All Other Fees





Total

$

2,398,000

$

2,090,000

Audit Fees. These were fees for professional services performed for the
audit of the Companys annual financial statements and review of financial statements included in the Companys filings on Forms 10-K and 10-Q, Sarbanes-Oxley
compliance, and services normally provided in connection with statutory and regulatory filings or engagements.

Audit-Related Fees. These were fees primarily for the
annual audits of the Companys employee benefit plan financial statements, internal control attestations in certain foreign jurisdictions and consultations by management related to financial accounting and reporting matters.

Tax Fees. These were fees primarily for advice and consulting services related to the structuring of
international operations, and the restructuring of business operations.

The Audit Committee has established policies and
procedures for the pre-approval of audit services and permitted non-audit services in order to ensure the services do not impair the auditors independence. The
Audit Committee will pre-approve on an annual basis the annual audit services engagement terms and fees and will also pre-approve certain audit-related services that may
be performed by the independent auditors up to the pre-approved fee levels, as well as permissible tax planning and compliance services. The Audit Committee may delegate
pre-approval authority to one or more of its members, but any pre-approval decision by such member or members must be presented to the full Audit Committee at its next
scheduled meeting. All services provided by and fees paid to KPMG LLP in 2017 were pre-approved by the Audit Committee in accordance with the pre-approval policies,
and there were no instances of waiver of approval requirements or guidelines during this period.

REPORT OF THE
AUDIT COMMITTEE

The Audit Committee is composed of four directors, each of whom is independent under the enhanced
independence standards for audit committees in the Exchange Act and the rules thereunder as incorporated into the listing standards of the NYSE and under the Companys Corporate Governance Guidelines, and two of whom have been determined by the
Board of Directors to be audit committee financial experts. The Audit Committee met seven times during 2017. The Audit Committee operates under a written charter adopted by the Board of Directors, which the Audit Committee reviews at least annually
and revises as necessary to ensure compliance with current regulatory requirements and industry changes.

As its charter
reflects, the Audit Committee has a broad array of duties and responsibilities. With respect to financial reporting and the financial reporting process, management, the Companys independent registered public accounting firm and the Audit
Committee have the following respective responsibilities:

Management is responsible for:



Establishing and maintaining the Companys internal control over financial reporting;



Assessing the effectiveness of the Companys internal control over financial reporting as of the end of each year; and



Preparation, presentation and integrity of the Companys consolidated financial statements.

The Companys independent registered public accounting firm is responsible for:



Performing an independent audit of the Companys consolidated financial statements and the Companys internal control over financial
reporting;



Expressing an opinion as to the conformity of the Companys consolidated financial statements with U.S. generally accepted accounting principles;
and



Expressing an opinion as to the effectiveness of the Companys internal control over financial reporting.

Overseeing and reviewing the financial statements and the accounting and financial reporting processes of the Company; and



Overseeing and reviewing managements evaluation of the effectiveness of internal control over financial reporting.

In this context, the Audit Committee has met and held discussions with management and KPMG LLP, the Companys independent registered
public accounting firm. Management represented to the Audit Committee that the Companys consolidated financial statements for the year ended December 31, 2017 were prepared in accordance with U.S. generally accepted accounting principles.
The Audit Committee has reviewed and discussed these consolidated financial statements with management and KPMG LLP, including the scope of the independent registered public accounting firms responsibilities, critical accounting policies and
practices used and significant financial reporting issues and judgments made in connection with the preparation of such financial statements.

The Audit Committee has discussed with KPMG LLP the matters required to be discussed pursuant to Public Company Accounting Oversight Board Auditing Standard No. 1301 (Communications with Audit
Committees). The Audit Committee has also received the written disclosures and communications from KPMG LLP required by the PCAOB regarding the independence of that firm and has discussed with KPMG LLP the firms independence from the Company.

In addition, the Audit Committee has discussed with management its assessment of the effectiveness of internal control over
financial reporting and has discussed with KPMG LLP its opinion as to the effectiveness of the Companys internal control over financial reporting.

Based upon its discussions with management and KPMG LLP and its review of the representations of management and the report of KPMG LLP to the Audit Committee, the Audit Committee recommended to the Board
of Directors that the audited consolidated financial statements be included in the Companys Annual Report on Form 10-K for the year ended December 31, 2017 for filing with the SEC.

Based solely on the Companys records and information provided by our directors, executive officers and beneficial owners of more
than 5% of the Common Stock, we believe that all reports required to be filed by our directors and executive officers under Section 16(a) of the Exchange Act were filed on a timely basis during 2017, except in the following instances:
(1) for Mr. P. Cody Phipps, the President, Chief Executive Officer and Chairman of the Company, an amendment to a timely filed Form 4 was filed to correct an administrative error in reporting the amount of securities acquired; (2) for
Mr. M. Jay Romans, a former executive officer of the Company, an amendment to a timely filed Form 4 was filed to correct an administrative error in reporting the amount of securities acquired; (3) for Ms. Barbara B. Hill and
Mr. Lemuel E. Lewis, directors of the Company, Form 4s were inadvertently filed late to report the acquisition of phantom stock, derivative securities beneficially owned through the Companys Directors Deferred Compensation
Plan.

Stock Ownership by Management and the Board of Directors

The following table shows, as of March 13, 2018, the number of shares of Common Stock beneficially owned by each director and
director nominee, the executive officers identified as our NEOs in the Summary Compensation Table in this Proxy Statement and all current directors and executive officers of the Company as a group.

Name of

Beneficial Owner

Sole Voting and Investment

Power (1)

Other (2)

AggregatePercentageOwned

Stuart M. Essig

27,847



*

John W.
Gerdelman

24,190



*

Barbara
B. Hill

6,506



*

Lemuel
E. Lewis

39,579



*

Martha
H. Marsh

16,065



*

Mark F.
McGettrick

1,397



*

Eddie N.
Moore, Jr.

28,688



*

James E.
Rogers

58,991



*

David S.
Simmons

14,102



*

Robert
C. Sledd

22,901



*

Anne
Marie Whittemore

74,316



*

P. Cody
Phipps

396,484



*

Richard
A. Meier

127,158



*

Stuart
Morris-Hipkins

62,061

Charles
C. Colpo

43,944



*

Rony C.
Kordahi

48,160



*

All
Executive Officers and Directors as a group (21 persons)

1,274,493



2.04

%

* Represents less than 1% of the total number of shares outstanding.

(1) No officer or director of the Company has the right to acquire any shares through the exercise of stock options within 60 days
following March 13, 2018.

(2) Includes: (a) shares held by certain relatives or in estates; (b) shares
held in various fiduciary capacities; and (c) shares for which the shareholder has shared power to dispose or to direct disposition. These shares may be deemed to be beneficially owned under the rules and regulations of the SEC, but the
inclusion of such shares in the table does not constitute an admission of beneficial ownership.

Stock Ownership
by Certain Shareholders

The following table shows, as of March 13, 2018, any person (including any group
as that term is used in Section 13(d)(3) of the Exchange Act) who, to our knowledge, was the beneficial owner of more than 5% of the Common Stock.

Name and Address of Beneficial
Owner

Shares Beneficially Owned

Percentage
Owned

BlackRock, Inc.

55 East 52nd Street, New York, NY 10055

6,672,191

(1)

10.79

%

Vanguard Group, Inc.

100 Vanguard Blvd., Malvern, PA 19355

5,734,515

(2)

9.28

%

Dimensional Fund Advisors LP

Building One, 6300 Bee Cave Road, Austin, Texas 78746

3,747,234

(3)

6.06

%

(1) Based upon a Schedule 13G report or amendment filed by BlackRock, Inc. with the SEC on
January 19, 2018.

(2) Based upon a Schedule 13G report or amendment filed by Vanguard Group, Inc. with the SEC on
February 9, 2018.

(3) Based upon a Schedule 13G report or amendment filed by Dimensional Fund Advisers LP with the SEC
on February 9, 2018.

Equity Compensation Plan Information

The following table shows, as of December 31, 2017, information with respect to compensation plans under which shares of Common Stock
are authorized for issuance.

Plan Category

(a)

Number of securities to

be issued upon exercise

of outstanding
options,

warrants and rights (1)

(b)

Weighted-average exercise

price of outstanding options,

warrants and rights
(1)

(c)

Number of
securitiesremaining available for futureissuance under equitycompensation plans(excluding securities reflectedin column (a))

Equity compensation plans approved by
shareholders (2)

360,556



1,292,281

Equity compensation plans not approved
by shareholders (3)







Total

360,556



1,292,281

(1) There are no outstanding options, warrants or rights as of December 31, 2017. The total in column
(a) above relate to performance shares.

(2) These equity compensation plans are the 2015 Stock Incentive Plan adopted
and approved by shareholders on April 30, 2015 and the 2005 Stock Incentive Plan. No additional awards may be made under the 2005 Stock Incentive Plan.

(3) The Company does not have any equity compensation plans that have not been approved by shareholders.

This Compensation Discussion and Analysis (CD&A) describes our executive compensation philosophy and programs, the compensation decisions made by the Compensation Committee under these
programs and the considerations that went into our decisions in light of the Companys performance in 2017.

2017 was
a year of strategic transformation for Owens & Minor in an effort to strengthen our core Domestic distribution and logistics business and to reposition the Company for future success as a global healthcare solutions company. At the outset
of 2017, the Company recognized that its core Domestic distribution and logistics business was under margin and competitive pressures as a result of market dynamics and vertically integrated competitors bundling and subsidizing distribution with
product margins. The business was also being impacted by the de-leveraging effect of the loss of a large customer in 2016.

To combat these pressures, the Board and executive management resolved to:

1)

Reduce expenses, increase efficiency and productivity and add significant operating income (to replace lost margin) through a rapid business transition or
RBT process,

2)

Advance the Companys previously stated four-part strategy, and

3)

Diversify the Company and its revenue/earnings profile into higher margin businesses through strategic transformational acquisitions that would further advance the
Companys strategy.

Recognizing the competitive pressures in the Domestic segment earnings (which makes up
the vast majority of the Companys revenue and operating earnings), in February 2017 the Compensation Committee approved the Companys 2017 Annual Incentive Plan (2017 AIP) for our NEOs that would:



Reduce potential payouts compared to fiscal 2016 for performance at or below the Board-approved annual operating plan (AOP) such that
reaching 100% of 2017 AOP target would result in 75% AIP performance; and

In 2017, the Company made significant progress on each of the three items above to advance the Companys business transformation:

1)

The Company outperformed the RBT financial goals and successfully added in excess of $50 million operating earnings through cost reductions and operational
improvements to partially offset margin compression and further identified an additional approximately $150 million of total run-rate earnings deliverable by 2020;

2)

The Company made significant qualitative progress against its previously announced four-part strategy, highlighted below. The strategic transformation is a multi-year
process and there is still progress to be made, as the Company will continue to pursue each of the four strategies.

Strategy

2017
Accomplishment

Build the Most Efficient Route to Market

The Company reduced operating expenses and made investments in capabilities (such as voice-to-pick technologies); however, the Company did not fully attain its productivity goals for 2017.

Expand along the Continuum of Care (COC)

The Company acquired Byram Healthcare, greatly expanding its capabilities and platform
along the COC. Additionally, the Company added an ambulatory surgery center customer with over 200 sites of care, further diversifying away from the acute setting to alternative points of care.

Become the Preferred Outsourcer to Manufacturers

The Company added strategic orthopedic product manufacturer customers, further
leveraging its distribution network to provide outsourced supply-chain and logistics services to manufactures for their clinically relevant products; however, the Company did not fully meet its revenue and margin goals for this business unit in
2017.

Data Analytics & Services

The Company made investments in its QSightTM inventory management platform and reorganized and enhanced its
selling capabilities for QSightTM and its other technology
and service solutions. Despite these investments, the Company did not fully meet its existing customer penetration goals in 2017 with respect to its value-added and service solutions.

3)

The Company made significant progress in transforming its earnings and revenue profile to higher-margin businesses through two strategic acquisitions:



The Company completed its acquisition of Byram Healthcare, the second largest U.S. home health distributor, on August 1, 2017, advancing its
strategy to expand along the continuum of care; and



On November 1, 2017, the Company announced its pending $710 million acquisition of Halyard Healths Surgical & Infection
Protection (S&IP) business (anticipated to close early in the second quarter of 2018). The Company expects this acquisition to provide the Company with market-leading brands in certain product categories, the ability to have
owned-brand products in excess of 10% of sales, and a scalable global manufacturing platform to leverage for future growth.

The Compensation Committee took the following significant compensation actions in 2017:



No NEO salaries were increased for 2017;



The 2017 AIP for our NEOs was designed so that NEOs would only earn 75% of target bonus opportunities for performance at the 100% level of the
Board-approved AOP; and



Long-term incentives provided an additional opportunity that would only be earned if Company performance in 2019 returns to previously stated adjusted
earnings per share growth goals.

In 2017, the Company and the NEOs successfully performed against a portion
of the Companys objectives, making significant progress on its business transformation while not meeting the target performance of adjusted operating earnings. The Company achieved annual GAAP earnings of $1.20 per share and adjusted earnings
of $1.61 per share for 2017, with consolidated operating earnings of $89.3 million and adjusted consolidated operating earnings of $180 million. For the purposes of determining financial performance for the 2017 AIP, adjusted operating
earnings was $166 million which was below the 2017 AOP target of $204 million but above threshold of $163.2 million.1.

We believe our 2017 compensation results are consistent with our 2017 operating performance and that the incentive awards earned by our executive officers reflected our performance and the performance of
our NEOs in 2017.



2017 adjusted operating earnings performance resulted in NEOs earning a 37% of target payout for the financial component of the 2017 AIP (weighted 80%
of the overall plan); and



The Compensation Committee exercised negative discretion on the individual Qualitative Performance Factor (QPF) component of the 2017 AIP
(weighted 20% of the overall plan) for Messrs. Phipps, Meier, Colpo and Kordahi for failure to meet certain financial and operational goals (as further described on page 46).

Summary of 2017 Compensation Actions and Performance Pay Results

Our 2017 Annual Incentive Program (AIP) was structured as follows:

1

Adjusted (non-GAAP) earnings and a reconciliation to its most comparable GAAP equivalent financial measure are described on page 17 of the Companys Annual Report
on Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018. In 2017, with the closing of the Byram Healthcare acquisition, the Company adopted a revised non-GAAP financial presentation that excludes
amortization of acquisition-related intangible assets in addition to items otherwise excluded. The 2017 AIP targets were approved prior to this accounting change and therefore amortization of acquisition-related intangible assets was not excluded by
the Compensation Committee for the purposes of determining financial performance for the 2017 AIP.

The Company did not achieve its LTI goals and therefore there was no payout on 2016-2017 LTI and all performance shares related thereto did not vest
and were forfeited.



Return on Invested Capital (ROIC) was less than 9% against a goal of 10% (and threshold of 9%).



Adjusted Diluted Earnings per Share was $1.49 against a target of $2.12 (and threshold of $1.90).

Transformational Performance-Based Retention Equity Award

While the Compensation Committee lowered the 2017 AIP target bonus opportunity for achieving target AOP performance, the Compensation Committee wanted to ensure that executives remain focused on
translating the near-term investments and cost reductions into building a stronger Company long-term and delivering on the goals of the Companys strategic transformation. Therefore, the Committee approved an additional performance-based LTI
opportunity designed to deliver the Companys transformational agenda and earnings goals through 2019. The value of the award at the time of grant equaled one-half of the recipients annual LTI award
value. These awards caused a modest increase in the total compensation for Messrs. Phipps, Meier and Colpo for 2017 as compared to 2016 as set forth in the Summary Compensation Table on page 54. These awards, which are more fully described on page
48, are entirely performance-based and require stretch financial performance over a multi-year period in order to vest.

Owens & Minors Compensation Philosophy and Goals

The
fundamental principle underlying Owens & Minors executive compensation program is that we pay for sustained performance, profitable growth and achievement of results. Our goal is to encourage high Company

and individual performance within a framework that allows us to attract, retain and motivate our executives. Components of our executive compensation program are designed to create the
appropriate balance between short- and long-term incentives and between fixed and at-risk compensation, to weigh cost against expected benefit and to align with the creation of shareholder value while
providing market-competitive compensation packages that promote executive retention. These components include:



Annual cash incentives to drive critical business goals for each year.

Reasonable but market-competitive base salaries so executives are not motivated to take excessive risks.



Retirement, severance and other benefits to attract executive talent and encourage retention.

Risks of Compensation Program and Practices

With respect to our overall compensation programs, the Company periodically reviews our compensation policies and practices to ensure that
they do not create risks that are reasonably likely to have a material adverse effect on the Company or encourage inappropriate risk-taking by executives. Additionally, the Compensation Committee and its independent Compensation Consultant, Semler
Brossy Consulting Group, LLC (Semler Brossy) consider risks when designing new executive compensation programs, and Semler Brossy periodically provides an external review of the programs and features of our programs and corporate
governance policies that help mitigate risk. In October 2017, management engaged in a formal compensation risk review and assessment process with input from Semler Brossy. Based on this review and assessments, we believe that our compensation
programs do not create risks that are reasonably likely to have a material adverse effect on the Company or encourage our executives to take excessive or inappropriate risks for our business. Our compensation philosophy and practices continue to
evolve into a more market-driven pay structure with a lower percentage of fixed pay and a higher percentage of variable and performance-based pay in order to enhance the programs pay for performance orientation. Further discussion and
disclosure of the Companys compensation policies and practices are included in the pages following this Executive Summary.

Our compensation programs and practices are designed to meet compensation best practices and to drive performance that creates long-term
shareholder value.

WHAT WE DO

☑

Pay for Performance. We link pay to performance and a significant portion of our
executives potential total annual compensation, both cash and equity, is based on the achievement of objective, simple and transparent financial measures that are structured to enhance short-term and long-term performance.

☑

Performance-Based Equity Awards. At least half of our annual equity award grants are
performance shares with multi-year performance requirements and an additional year of vesting on earned shares.

☑

Share Ownership Guidelines. We have established stock ownership guidelines for our officers,
and all of our NEOs meet or exceed the established ownership guidelines (Mr. Morris-Hipkins and Mr. Kordahi, who joined the Company in 2017 and 2016, respectively, have five years from the date of hire to meet the guidelines and currently
are on track to do so).

☑

Limited Perquisites. We tie perquisites to a legitimate business purpose and limit the value
provided to executive officers.

☑

Double-Triggered Change in Control Provisions. Equity vesting and severance payments and
benefits based on a change in control require termination of employment following the change in control.

☑

Recoupment Policy. We have in place a recoupment policy to recover from our executives
compensation paid under circumstances involving restatement of our financial statements due to misconduct.

☑

Risk Mitigation. We seek to mitigate risks associated with compensation by establishing caps
on incentive compensation, multiple performance targets for earning incentive compensation and ongoing processes to identify and manage risk. We do not believe our compensation program creates risks that are reasonably likely to have a material
adverse impact on the Company, which we confirm annually through a risk assessment of incentive-based compensation.

☑

Independent Compensation Consulting Firm. The Compensation
Committee receives advice about its compensation programs and practices from an independent consulting firm that provides no other services to the Company, and the Company is not aware of any conflicts of interest with respect to its
work.

WHAT WE DONT DO

☒

No Employment Agreements. While we agreed to an employment term sheet upon the hiring of our
new CEO in 2015, we do not otherwise have employment agreements with our executive officers.

☒

No Hedging. We prohibit our executive officers and directors from hedging against the
economic ownership of Company stock.

☒

No Pledging. We prohibit our executive officers from pledging Company stock.

☒

No Re-pricing of Equity Awards. Our stock plans do
not permit the re-pricing of equity awards.

☒

No Tax Gross-Ups. We
do not provide any tax gross-ups, including excise tax gross-ups on change in control severance payments and benefits.

In May 2017, our shareholders approved the compensation of our NEOs for 2016 in our say-on-pay advisory vote with over 94% of votes cast in support of the program. Based on this support, the Compensation Committee made no material changes to the core structure and philosophy behind our
executive compensation program in 2017 but continues to evaluate our pay programs and practices to ensure that they are both market competitive and equitable. At our upcoming 2018 Annual Meeting, our shareholders will provide an advisory vote to
approve 2017 executive compensation, and the Compensation Committee will continue to consider results from these advisory votes in setting executive compensation.

The Process for Setting Executive Compensation

The Companys
executive compensation levels and programs are established, approved and administered by the Compensation Committee, which is currently composed of five independent directors. The Compensation Committee solicits the views of its independent outside
consulting firm and senior management on incentive compensation and plan design issues. In addition, the Compensation Committee sets performance goals and evaluates the performance of our Chief Executive Officer on an annual basis jointly with the
Governance & Nominating Committee, and the Chief Executive Officer sets performance goals and provides performance evaluations of our other executive officers and makes recommendations as to their compensation levels. Our Chief Executive
Officer does not make recommendations to the Compensation Committee with respect to his compensation and does not participate in Committee meetings when his compensation is discussed.

Independent Advisor. The Compensation Committee has the authority under its charter to retain independent
consultants or advisors to assist it in gathering information and making decisions. Management may not engage any independent advisor retained by the Compensation Committee to perform services without the prior approval of the committee, and no such
engagement by management was undertaken in 2017. The Compensation Committee also obtains information and assistance from the Companys human resources and finance department in evaluating and making decisions on executive compensation.

The Compensation Committee continued to engage Semler Brossy in 2017 as its independent advisor to (1) provide
recommendations in changes to our peer group; (2) provide guidance and advice in our search for new executive officers and the compensation package offered to those new leaders; (3) analyze competitive levels of each element of
compensation and total compensation for each of the executive officers relative to our peer group and industry trends; (4) provide information regarding executive compensation trends and regulatory changes and developments; (5) provide
input on annual and long-term incentive design; and (6) periodically assist in conducting a risk assessment of our compensation programs, policies and practices. The Compensation Committee has analyzed whether the work of Semler Brossy has
raised any conflict of interest and has concluded that the work of our advisor, including the individuals employed by our advisor who provide consulting services to the committee, has not created any conflict of interest. The Compensation Committee
also considered and confirmed the independence of legal advisors retained during 2017.

Factors Used to Determine Executive
Compensation. Consistent with past years, the Compensation Committee considered a variety of factors in making decisions regarding compensation for our NEOs in 2017. The primary factors were as follows:

Performance. Our policy is to provide executive officers with compensation opportunities that are based
upon Company performance and their contribution to Company performance.

Mix of Short-Term and Long-Term
Compensation. Because the successful operation of our business requires a long-term approach, one element of our executive compensation program is long-term compensation. Although we have never had specific policies on the
percentage of total compensation that should be short-term versus long-term, we considered this relationship in determining the overall balance and reasonableness of our

executives total direct compensation packages. We believe that short-term compensation is necessary in conjunction with long-term compensation to provide remuneration for performance of the
short-term goals or milestones that ultimately lead to achievement of our long-term objectives and strategic initiatives. In 2017, the Compensation Committee gave additional consideration to the Companys transformational and strategic
acquisition activities and the importance of incentivizing and retaining key leaders to deliver upon these long-term goals.

Mix of Performance-Based Compensation. To create a strong link between pay and performance, a significant
portion of compensation is based on the achievement of objective financial measures. We have no specific policies on the percentage of total compensation that should be performance-based, but consider this relationship in determining the
overall balance and reasonableness of the executives total direct compensation packages.

Impact and Mix of Cash vs. Non-Cash Compensation. We consider both the cost and the motivational value of the various components of compensation. Although we have no specific policies on the percentage of total
compensation that should be cash versus equity, we consider this relationship in determining the overall balance and reasonableness of the executives total direct compensation packages.

Peer Group Comparisons. Each year, we evaluate our compensation levels and programs through comparisons to
available information for a group of peer companies selected by the Compensation Committee (Peer Companies) based in part on recommendations from and analyses prepared by our compensation advisors. This evaluation helps us to assess
whether our level and mix of executive pay is competitive and reasonable when compared to certain industry standards.

In general, the Peer
Companies were selected after consideration of the following factors:

Our Peer Companies include a mix of health care distribution and companies
from other distribution industries in order to capture companies of comparable business model and size to us. The Compensation Committee periodically reviews the peer group to ensure it remains appropriate and relevant as a market reference and
modifies the peer group as necessary to reflect changes at Owens & Minor, among the peers or within the industry. Relative to the Quantitative Factors of the Peer Companies, Owens & Minor generally ranks between the 25th percentile and median of the group. The Peer Companies used for 2017
consisted of the following:

2017 Peer Companies

Anixter International

Synnex Corp.

C.H. Robinson Worldwide,
Inc.

United Natural Foods, Inc.

Essendant Inc.

Univar, Inc.

Genuine Parts Company

WESCO International

Henry Schein, Inc.

VWR Corporation

J.B. Hunt Transport Services,
Inc.

WestRock Co.

Patterson Companies,
Inc.

Using the Peer Companies, Semler Brossy analyzed the compensation components and levels for the NEOs of
the Peer Companies and prepared a comparison of 2017 target total direct compensation and each element thereof to reported information for the Peer Companies. The Compensation Committee also considered data from

a Towers Watson General Industry survey, using a survey cut incorporating a discount to Owens & Minors revenue in light of the low-margin
nature of the Companys business relative to general industry companies. When the Compensation Committee reviews data from the Peer Companies, it considers the 50th percentile of the group as a reference point for positioning target total compensation. This is a reference point, not
a policy, and actual compensation may be above or below the target level based on performance. Data from the Peer Companies is one of a number of factors considered by the Compensation Committee when determining each executives pay. Other
factors considered during this process include, but are not limited to, the executives performance, internal equity of pay, general market competitiveness and whether or not the executive participates in the
now-frozen Company SERP program.

Tally Sheets. We also
review total compensation levels for executive officers at least annually through the use of tally sheets that quantify each element of direct and indirect compensation provided to individual executives and the portion of the executives total
compensation represented by each element of compensation. This annual review of tally sheets also includes information on the value of executives outstanding equity awards, as well as an evaluation of the payments and benefits that would be
paid to executive officers in the event of termination of employment, including retirement or following a change in control of the Company. While providing additional context to us in making compensation decisions, the information from the tally
sheets regarding outstanding equity awards and termination payments and benefits generally does not affect our compensation decisions for the NEOs. This reflects our view that an executives compensation level should be based on the
Companys performance, the executives performance and the executives contribution to the Companys performance.

Total Program Cost. We consider the cost (including aggregate share usage and dilution) of the various components of our compensation program in evaluating the overall
balance and reasonableness of our executives total direct compensation packages.

Risk
Considerations. In setting executive compensation, the Compensation Committee reviews the various components of our program to consider whether they are appropriately structured to promote the achievement of our business
goals without encouraging the taking of unnecessary risks. We believe that several elements of our program mitigate risks associated with performance-based compensation, including the following:



Limits on Incentive Compensation. Awards under our annual incentive program are capped at 200% of the executives target award to protect
against excessive short-term incentives, and the Compensation Committee has discretion to reduce awards based on factors it deems appropriate, including whether officers took unnecessary risks.



Performance Metrics. We use a combination of financial performance metrics for our annual incentive program that emphasizes profitable and
disciplined growth and requires responsible and risk-based decision-making by our executives.



Performance Shares/Long-Term Equity Awards. At least half of an executives equity compensation each year consists of performance shares
with a two-year performance cycle and an additional year of service-based vesting, which focuses management on sustaining the Companys longer-term performance. The other portion of an executives
equity compensation each year consists of restricted stock awards that vest over a period of at least three years and, accordingly, further encourages a focus on long-term performance.

Recoupment Policy. Performance-based cash and equity compensation to our executive officers is subject to recoupment under circumstances
involving misconduct that results in a restatement of our financial statements.

 Performance shares are
earned if the Company achieves return on capital employed and adjusted diluted EPS metrics. Performance is measured over a 2-year period and, if earned, shares vest at the end of 3 years from date of
award.

 Restricted stock vests 3 years from date of grant

 For 2017, additional
performance shares were awarded to the NEOs and certain other employees of the Company in order to incentivize and retain key leaders and high-performing teammates to deliver the Companys transformational agenda and earnings goals through
2019.

Rewards performance that enhances shareholder value through the use of equity-based awards
that link compensation to the value of our Common Stock and the achievement of multi-year performance goals; strengthens the alignment of management and shareholder interests by creating meaningful levels of Company stock ownership by
management

Deferred Compensation Plan

Officers may defer salary and cash bonuses into a plan that provides for investment options similar to the Companys 401(k) plan.

Provides a tax efficient opportunity to save for retirement and to ensure that our executive compensation program remains
competitive in the marketplace for key executive talent

Retirement/Post-Termination

Compensation

Participation in Companys 401(k) plan and matching contributions similar to other teammates. SERP (frozen as of March 2012) available
to legacy NEOs only (see Summary Compensation Table, Note 3).

Provides security for the future needs of the executives and their
families

We believe that the elements of our executive compensation framework support short-term
and long-term performance goals by providing our executive officers with an appropriate mix of compensation elements that include (1) fixed annual compensation, (2) target-based annual and long-term incentive compensation and
(3) security for the future needs of the executives and their families in the form of retirement and termination benefits.

Base Salary

While we agreed to an employment term sheet upon the hiring of
our new CEO in 2015, our executive officers are otherwise employed on an at will basis and without employment agreements. We review base salaries each April.

In making base salary decisions the Compensation Committee generally considers:

(1) Individual attributes of each NEO (such as responsibilities, skills, leadership and experience),

(2) Individual and overall Company performance levels,

(3) The officers expected future contributions to the Company, and

(4)
Overall market-competitiveness of the officers base salary.

In 2017, the Compensation Committee did not approve salary
increases for our NEOs and all NEO salaries were held at the 2016 level. In making this decision, the Compensation Committee gave significant weight to the Companys expected financial performance level in 2017 and the fact that financial goals
for 2017 were well-below actual financial performance delivered in 2016 due to expected margin pressures and competitive dynamics in our Domestic business.

Annual Incentives

We provide annual incentive opportunities to executive
officers to motivate their performance in achieving our current-year business goals. Each year, we establish an AOP for that year that includes financial, strategic and other goals for the Company and that is approved by the Board of Directors.
Annual incentive goals for the executive officers are set based on the approved AOP. These goals are weighted to reflect their relative importance and contribution to overall Company performance.

The performance metrics (Performance Metrics) established for determining the Target Payout Amount for the 2017 AIP were:



Company Adjusted Operating Earnings comprising 80% of the Performance Metric with the following targets:

In addition, none of the foregoing Performance Metrics could result in a payout unless
the Company achieved an adjusted operating earnings for 2017 of at least $130 million (the Qualifier).

The
Compensation Committee selected, and the Board of Directors approved, the Qualifier and each of the Performance Metrics, including the weights assigned to them and the target achievement levels in March 2017 based on discussions with and
recommendations by senior management, the approved 2017 AOP, the growth and operational improvements called for in our strategic plan and transformational agenda, and consultations with Semler Brossy. The Committee selected Adjusted Operating
Earnings as the financial Performance Metric for our annual cash incentive plan because this metric:



is a common metric to all of our business units,



is widely understood by our teammates and the internal metric of greatest focus,



is one of the most important underlying drivers of business performance and other financial metrics (such as adjusted diluted EPS, operating cash flow
and return on invested capital),



is aligned with creating shareholder value as sustained adjusted operating earnings is both highly correlated with share price growth and a key driver
of free cash flow to shareholders which is also highly correlated to equity value,



is aligned with our investor communications and the area of focus of our investor base, and



is in part driven by our performance of our transformation agenda and RBT initiatives.

The Compensation Committees goal in setting the target achievement levels was to provide management with challenging yet reasonably
achievable goals that would lead the Company to meeting its 2017 business plan and position the Company to ultimately achieve the growth, transformation and improvement targets in our strategic plan without encouraging excessive risk-taking
behavior. We believe that the use of a key financial performance metric that rewards profitable growth, as well as a qualitative performance metric to assess individual efforts and goal achievement, provides a balanced assessment of performance. The
Compensation Committee retains authority to reduce or eliminate incentive compensation, which allows the committee to make judgments as to compensation it believes is excessive in light of performance as well as to monitor and respond to any
behavior that it believes could be detrimental to the Company.

In structuring the 2017 financial Performance Metrics, the
Compensation Committee took into account several unique factors for 2017 including (1) that expected 2017 financial results were expected to be lower than 2016 performance, (2) that the Companys Domestic business segment was facing margin
compression and intensifying competitive dynamics, and (3) that the Company needed to retain and incentivize key leaders, including the NEOs, to deliver 2017 performance and reposition and transform the Company for the future. As a result, the
Compensation Committee structured the financial performance metrics to allow for pro-rated AIP payout at a lower threshold (80% of AOP achievement), reduced payout of AIP at 100% AOP attainment and a steeper
AIP curve for performance in excess of 100% of AOP. Additionally, no amount would be payable in

respect of any Performance Metrics for achievement below the Threshold Payout Amount or if the Company did not achieve the Qualifier. The AIP structure resulted in a 2017 AIP curve as follows:

The Companys 2017 adjusted operating earnings performance of $166 million resulted in
achievement of 37% of target for the financial component of the NEOs 2017 AIP (weighted 80% of the overall plan).

Originally introduced in 2015, the Compensation Committee retained a QPF as a performance metric that, subject to meeting the Qualifier,
would allow a portion of any incentive compensation earned by the NEOs to be based on an overall assessment of the NEOs job performance relative to leadership, performance against position-specific goals, strategic focus, management skills and
other factors. The Compensation Committee believes that inclusion of the QPF is a way to reward strong performance and leadership that may or may not have translated into achievement of other financial and operating targets during the year, but that
were nonetheless important achievements contributing to future value creation. The NEOs individual performance goals and key performance indicators that were used to determine the NEOs QPF included the following:

 Enhance International Segment IT platform to make it a competitivedifferentiator

The Compensation Committee reviewed the performance of each individual NEO against his respective goals.
After review, the Compensation Committee exercised negative discretion for 2017 incentive awards as they relate to Messrs. Phipps, Meier, Kordahi and Colpo as a result of: for Mr. Phipps, the Companys 2017 overall financial performance,
financial performance of our International segment and failure to fully-meet operational productivity goals in Domestic segment; for Mr. Meier, the Companys 2017 overall financial performance and the financial performance of our
International segment; for Mr. Colpo, the financial performance of our International segment; and, for Mr. Kordahi, the Companys failure to fully-meet operational productivity goals in our Domestic segment. The exercise of negative
discretion resulted in attainment of the QPF at 18.5% for each of Messrs. Phipps, Meier, Kordahi and Colpo. The Compensation Committee determined that Mr. Morris-Hipkins had met his 2017 QPF goals at the full 37% level.

The table below sets forth (i) the Performance Metrics, their respective weightings, achievement levels at threshold, target and
maximum as well as actual results in 2017 for each financial Performance Metric and (ii) the Qualifier and actual achievement level required for the payment of any incentive compensation under the Annual Incentive Program.

(1) For achievement levels above threshold but below target or above target but below
maximum, payout amounts would be calculated based on a straight-line interpolation of the achievement level above threshold or target, as applicable.

(2) For purposes of the 2017 Annual Incentive Program, and in accordance with the terms of the program as approved by the Compensation Committee, adjusted results for the applicable performance metrics as
provided in the Companys Annual Report on Form 10-K for the year ended December 31, 2017, filed with the SEC on February 23, 2018. In 2017, the Company adopted a revised non-GAAP financial presentation that excludes amortization of acquisition-related intangible assets in addition to items otherwise excluded. The 2017 AIP targets were approved prior to this accounting change and
therefore amortization of acquisition-related intangible assets has not been excluded in this table.

(3) As discussed in this
CD&A, in determining achievement of the QPF for each NEO, the Compensation Committee reviewed their accomplishments and contributions in 2017 results as well as performance of their individual goals. QPF for our NEOs ranged between 18.5% and
37%.

Based on the foregoing results and the Compensation Committees review of individual NEO performance, each NEO
received the following payout under the 2017 AIP:

Name

2017 AIP Target as
% of Base Salary

2017 AIP Target ($)

Financial Performance Results

(80%
weighting)

QPFResults

(20% weighting)

2017 AIP

2017 AIP as

% of Target

P. Cody
Phipps

125

%

$

1,153,125

37

%

18.5

%

$

383,991

33

%

Richard
A. Meier

75

%

$

489,871

37

%

18.5

%

$

163,127

33

%

Stuart Morris-Hipkins

70

%

$

297,500

37

%

37

%

$

91,730

37

%

Charles
C. Colpo

50

%

$

228,448

37

%

18.5

%

$

76,073

33

%

Rony C.
Kordahi

70

%

$

315,000

37

%

18.5

%

$

104,895

33

%

(1) Mr. Morris-Hipkins 2017 incentive payout is
pro-rated based on time in position during 2017 (10 months)

Long-Term Incentives

Our shareholder-approved 2015 Stock Incentive Plan permits us to award grants of non-qualified stock options, incentive stock options, stock awards, performance
share awards, stock units and stock appreciation rights. Except in instances of initial executive hiring, job promotions, retention concerns and similar circumstances, we grant equity awards to executive officers
one-time each year. The Compensation Committees decision to grant equity-based awards is discretionary and largely determined by the Companys longer-term financial performance, strategic
accomplishments and individual contributions. Equity award decisions may also be based upon individual performance, expected future performance, job promotions and the assumption of greater responsibility within the Company. We strive to maintain an
appropriate balance between the aggregate number of shares used for equity grants (relative to the competitive landscape) and shareholder interests.

We make annual equity award grants to senior management in two forms: (1) restricted stock that vests after a three-year period during which the officer is continuously employed by the Company; and
(2) performance share awards that are earned based on achievement of designated performance metrics over a two-year period followed by a one-year holding period
during which the officer must remain in the Companys employ. We believe that the mix between these vehicles helps provide a balance between linking compensation to the achievement of multi-year performance goals and strengthening the alignment
of management and shareholder interests by creating meaningful levels of Company stock ownership by management. The Company has not issued stock options to its officers since 2007.

In accordance with our standard practice, the grant of the 2017 annual equity awards
was made at the first meeting of our Board in 2017 on February 9, 2017, a date that is scheduled more than one year in advance. The grant values are based on the closing price of the stock on the date of grant and the number of shares subject
to the award.

When making 2017 long-term incentive equity award determinations, the Compensation Committee focused on the
Companys longer-term financial performance and balanced the need to align the NEOs financial interests with those of shareholders against considerations regarding the affordability of equity grants, including aggregate share usage,
dilution and accounting costs. We have historically been below median relative to the Peer Companies in our equity award grants to minimize share usage, dilution and accounting costs but are gradually evolving to increased long-term incentives (with
more performance shares) relative to other elements of compensation in an effort to make our compensation program more performance-based and market driven.

Additionally, as discussed earlier in this CD&A, in 2017 the Compensation Committee granted additional Performance Shares designed to retain and incentivize NEOs and certain key leaders to deliver the
Companys transformational agenda and financial performance through December 31, 2019. Vesting of these Performance Shares is contingent on the Company reaching certain levels of adjusted earnings per share for calendar year 2019. The
Company expects to disclose the results of these awards in its 2020 proxy statement after the performance period has concluded and financial performance has been measured.

Based on the foregoing considerations, the Compensation Committee granted the following long-term incentive awards in 2017 having the indicated grant date fair values:

2017 Long-Term Incentive
Awards (1)

Name

Performance

Shares

(2)

Restricted

Stock

(3)

TransformationPerformanceShares

(4)

Sign-onAward ofRestrictedStock

Total

P. Cody
Phipps

$

2,000,007

$

2,000,007

$

999,986

$



$

5,000,001

Randy R.
Meier

350,015

350,015

350,015



1,050,044

Stuart
Morris-Hipkins (5)

350,017

350,017

350,000

285,004

1,335,037

Charlie
C. Colpo

155,993

155,993

155,993



467,979

Rony C.
Kordahi

350,015

350,015

350,015



1,050,044

(1) The amounts shown are the aggregate grant date fair value of the awards computed in accordance with
FASB ASC Topic 718 and, in the case of performance shares, are based on probable achievement at target levels.

(2) These
performance shares generally require achievement by the Company of specific financial metrics (discussed below) for fiscal years 2017 and 2018 as a condition to issuance of the underlying shares of restricted stock (which, if earned, would vest on
the third anniversary of the performance share award). Amounts in the table reflect the values if achieved at the target level. Mr. Phipps long-term incentive compensation and equity targets are higher relative to the other NEOs to
reflect the broader scope of his responsibilities and authority and his greater ability to impact the Companys performance.

(3) These shares of restricted stock vest three years from the date of grant based on the executives continued employment with the Company.

(4) The performance shares were a special, unique award designed to retain NEOs and incentivize delivery of our transformation and 2019
financial goals. Amounts in the table reflect the values if achieved at the target level.

(5)
Sign-on time-based restricted stock granted in connection with commencement of employment with the Company.

The table below shows the metrics, weights and performance levels established for the
2017 performance share awards. The Compensation Committee approved 2017 adjusted earnings per share (adjusted diluted EPS) and two-year (2017-2018) average return on capital employed (ROCE), weighted 80% and
20%, respectively, as metrics for the long-term incentive performance shares that were granted in 2017. The Compensation Committee choose adjusted diluted EPS as a financial metric because this metric:



is the metric of greatest attention by analysts and our investors,



is aligned with shareholder value as sustained adjusted diluted EPS growth is both highly correlated with share price growth and adjusted diluted EPS
is a key driver of free cash flow to shareholders which is also highly correlated to equity value,



is consistent with our message to shareholders that our focus is on consistent earnings growth,



is widely understood by award recipients, and



is impacted and driven in part by our performance of Transformation Agenda initiatives.

In addition to adjusted diluted EPS, the Compensation Committee selected ROCE as a performance metric because:

the metric measures profitability and value creation over time as derived from the Companys use of capital which can create value for
shareholders, and



a significant portion of our shareholder base and analysts believe that efficient use of capital employed is an important metric of our performance.

2017 Performance Share Award Metrics

Performance Metric (1) (2)

Weight

Threshold

Target

Maximum

Adjusted
Diluted EPS

80%

$1.94

$2.15

$2.58

Average Return on Capital Employed
(ROCE)

20%

11.5%

12.8%

15.4%

(1) For achievement levels above threshold but below target, or above target but below maximum, share
payout amounts would be calculated based on a straight line interpolation of the achievement level above threshold or target, respectively. There is no payout for achievement below threshold.

(2) The average return on capital employed metric is measured over the 2017 and 2018 calendar years and the adjusted diluted EPS metric
is measured for the calendar year 2018 and based on the applicable weights and achievement levels will result in the issuance of restricted stock to each officer.

Payouts on 2016 Performance Share Awards. Based the Companys failure to achieve the two-year performance metrics under
the Performance Share Awards granted in 2016, the NEOs did not earn the performance share awards that were issued in 2016. These shares will not vest and will be forfeited.

(1) For purposes of the 2016 Performance Share Awards, and in accordance with the terms
of the underlying agreements approved by the Compensation Committee, adjusted results for the applicable performance metrics as provided in the Companys Annual Report on Form 10-K for the year ended
December 31, 2017.

Common Stock Ownership Guidelines. We have established Common Stock
ownership guidelines for our executive officers that are expected to be achieved and maintained. Under these guidelines, officers are given approximately five years to reach the full target ownership amount with interim targets to meet each year. As
of December 31, 2017, each continuing NEO had achieved his or her applicable target ownership level (Mr. Morris-Hipkins and Mr. Kordahi, who joined the Company in 2017 and 2016, respectively, have five years from the date of hire to
meet the guidelines and currently are on track to do so). Because of the historical success of these guidelines in maintaining meaningful stock ownership levels among management, the Company has not imposed any further stock retention requirements
on its executive officers in connection with stock option exercises or vesting of restricted stock.

The ownership guidelines
are as follows:

Officer

Value of Common Stock

Chief Executive Officer

6.0 x Base Salary

President

3.0 x Base Salary

Executive Vice Presidents

2.0 x Base Salary

Senior Vice Presidents

1.5 x Base Salary

Vice Presidents, Regional Vice Presidents

1.0 x Base Salary

The Chief Executive Officers higher ownership target reflects the larger portion of his total
compensation represented by long-term incentive award value. Eligible holdings in meeting these targets include direct holdings, indirect holdings, shares held through Company plans such as the teammate stock purchase plan, and restricted stock
holdings (but excluding any stock options).

2018 Stock Incentive Plan

The Board of Directors has approved, adopted and submitted for shareholder approval the 2018 Stock Incentive Plan which is more fully
discussed under Approval of the Owens & Minor, Inc. 2018 Stock Incentive Plan beginning on page 18 of this proxy statement.

Retirement/Post-Termination Compensation

Retirement
Compensation

The Company believes that retirement compensation is an essential component of an overall market competitive
total executive compensation package in that it provides security for the future needs of the executives and their families. The NEOs are entitled to participate in the Companys 401(k) plan and receive Company matching contributions in the
same manner as other Company teammates.

The Company provides supplemental retirement benefits under a Supplemental Executive
Retirement Plan (the SERP), as further described on page 59 of this proxy statement under Retirement PlansSupplemental Executive Retirement Plan. At the time of its implementation in 1991, the SERP was designed to be
competitive relative to defined benefit pension plans offered by other companies and to reward officers who provided long-term service to the Company, thereby promoting retention of highly performing executive talent. In 2012, the Compensation
Committee amended the SERP to freeze both benefit levels and participants effective March 31, 2012, as part of an effort to make our overall executive compensation program more performance-based. Of the NEOs, Mr. Colpo is the only
remaining participant in the SERP.

The Company has an Executive Deferred Compensation and Retirement Plan into which officers and other management-level personnel may defer
salary and cash bonus. The purpose of the deferred plan is to provide security for current and future needs of the participants and their families by providing a tax efficient opportunity to save for retirement and to ensure that our compensation
program remains competitive in the marketplace for key management talent. This plan provides for similar investment options as under our 401(k) plan. For participants in this plan, the Company matches a total of up to 5% of 401(k) and deferred
compensation plan contributions combined; provided that the participant has first maximized contributions under the 401(k) plan.

Change in Control Agreements

The Company has entered into change in
control agreements (CIC Agreements) with its officers, including each of the NEOs, as described on page 62 of this proxy statement under Potential Payments upon Termination or Change in ControlChange in Control
Agreements. The purpose of the CIC Agreements is to encourage key management personnel to remain with the Company and to help avoid distractions and conflicts of interest in the event of a potential or actual change in control of the Company
so that executives will focus on a fair and impartial review of the acquisition proposal and the maximization of shareholder value despite the risk of losing their employment. The Compensation Committee believes that the CIC Agreements help it to
attract and retain key executive talent that could have other employment alternatives that may appear to be less risky absent these arrangements. The Compensation Committee further believes that it has structured these agreements to be reasonable
and to provide a temporary level of income protection to the executive in the event of employment loss due to a change in control.

The CIC Agreements do not provide for excise tax gross-up payments. In addition, the severance payment obligation under the CIC Agreements has a double
trigger such that the payment of a severance benefit may only be made if there is a change of control and the officers employment with the Company is terminated by the Company without cause or by the officer for good reason within 24
months after such change in control. We believe that this structure strikes an appropriate balance between the incentives and the executive hiring and retention effects described above, without providing these benefits to executives who continue to
enjoy employment with an acquiring company in the event of a change of control transaction. Annually in connection with the review of executive compensation tally sheets, the Compensation Committee reviews the severance amounts that would be payable
to each NEO upon a change in control to ensure that the amounts are reasonable in light of the purpose of the agreements and relative to the marketplace generally. However, these amounts did not affect the Compensation Committees compensation
decisions with regard to any specific element of our 2017 executive compensation program.

Equity awards have the same
double-trigger feature discussed above for accelerated vesting and exercisability, as applicable, in the event of a change in control. These same terms apply to the equity awards of all other teammates in the Company upon a change in
control.

The CIC Agreements renew on a
year-to-year basis unless terminated by the Company with a notice of non-renewal.

Severance Policy

We have a formal severance policy described on page 64 of this proxy statement under Potential Payments upon Termination or Change in ControlSeverance Policy that applies to all
corporate officers who are involuntarily terminated without cause (or who resign at the request of the Company). We adopted this policy to promote management stability and provide consistent and fair treatment to our departing officers in
circumstances where their performance does not constitute cause for employment termination. We believe the severance policy helps the Company attract and retain key executive talent that could have other employment alternatives that may appear to be
less risky absent such a policy. The severance policy is designed to provide the

officer with continued compensation and assistance for 18 months following dismissal in an effort to assist him or her in finding new employment and is conditioned upon the officer entering into
a non-competition,non-solicitation and confidentiality agreement for the benefit of the Company.

Other Benefits

In addition to the components of compensation discussed above, we provide certain other limited benefits to executives, including the NEOs, to help maximize the time key executives are able to spend on
the Companys business; to reward experience, expertise, responsibility, seniority, leadership qualities and advancement; and to ensure that our executive compensation program remains competitive in the marketplace for key executive talent.
These other benefits consist of the following and are specifically disclosed by amount in note 4 to the Summary Compensation Table on page 54 of this proxy statement: funding of life insurance policy premiums (provides security for current and
future needs of the executives and their families), automobile allowance or lease (ensures transportation for business travel needs, recognizing that the automobile may also be used for personal purposes), tax and financial planning and tax return
preparation assistance (allows executives to concentrate on business matters rather than on personal financial planning), and annual physical and enhanced medical access (identifies and addresses medical issues and helps preserve the Companys
investment in its executives by encouraging them to maintain healthy lifestyles and be proactive in addressing potential health issues). In addition, NEOs may participate in our health and welfare plans, 401(k) plan and teammate stock purchase plan
on the same basis as other full-time teammates. Finally, except under limited and unusual circumstances, we only pay for executive travel on commercial or private aircraft when such travel is integrally and directly related to the performance of the
executives duties for the Company and is not personal in nature. We do not provide tax gross-ups on any income executives may realize as a result of the foregoing benefits.

Recoupment Policy

In an
effort to mitigate any imprudent risk-taking behavior associated with incentive compensation, the Company has a policy that permits the recoupment of performance-based cash and equity compensation paid to executive officers. This compensation is
recoverable from an executive officer if:

(i)

The payment or award was predicated upon the achievement of certain financial results that were subsequently the subject of a restatement of the Companys
financial statements;

(ii)

The Board (or its designated Compensation Committee) determines that the executive engaged in misconduct that caused or substantially caused the need for the
restatement; and

(iii)

A lower payment would have been made to the executive officer based upon the restated financial results.

If the foregoing conditions are met, as determined by the Board (or its designated committee), the Company, under terms of the applicable
program or award agreements, will recover from the executive officer the amount by which his or her performance-based compensation for the relevant period exceeded the amount (if any) that would have been paid based on the restated financial
results. The Board (or its designated committee) may take such further action as it deems necessary or appropriate to remedy the misconduct and prevent its recurrence. The recoupment policy currently will not apply to performance-based compensation
after the second anniversary of the date on which such compensation was paid. We continue to monitor additional requirements that may be imposed pursuant to Section 304 under the Sarbanes-Oxley Act of 2002 and that would lead to modification of
this policy to the extent required by the Dodd-Frank Act of 2010 and the related final rules of the SEC.

Hedging and Derivatives Trading
Prohibition

The Company has policies that prohibit directors, officers and other teammates with access to confidential
information of the Company from engaging in certain transactions relating to our common stock, including buying or selling options and short sales. We also prohibit these individuals from hedging the economic risk of ownership of our common stock
and holding our stock in a margin account or pledging our stock as collateral for a loan.

Section 162(m) of the Internal Revenue Code generally precludes a tax deduction by any publicly-held company for compensation paid to any covered employee to the extent the compensation
paid to such covered employee exceeds $1 million during any taxable year of the company. The Tax Cuts and Jobs Act of 2017 was enacted in the United States in December 2017 and included changes to Section 162(m) effective for years
beginning in and after 2018. Prior to 2018, covered employees included the Chief Executive Officer of the company and the three other highest paid officers of the company (other than the Chief Financial Officer). For 2018 and later
years, covered employees will include the Chief Executive Officer of the company, the Chief Financial Officer of the company, the three highest paid officers of the company (other than the Chief Executive Officer and the Chief Financial
Officer) and any employee who qualified as a covered person for any tax year beginning after 2016. For years beginning prior to January 1, 2018, the $1 million deduction limit did not apply to qualified performance-based
compensation that is based on the attainment of pre-established, objective performance goals established under a stockholder-approved plan. Effective for the years beginning on or after January 1,
2018, there is no exception for qualified performance-based compensation from the Section 162(m) limitation; but, a transition rule provides that the qualified performance-based compensation exemption will continue to
apply to awards that are made pursuant to a binding contract in effect on or before November 2, 2017, that is not materially modified thereafter. A number of requirements must be met under Section 162(m) in order for particular
compensation to so qualify for the exception such that there can be no assurance that qualified performance-based compensation will be fully deductible under all circumstances. We believe that it is important to preserve flexibility in
administering compensation programs to promote various corporate goals. Accordingly, we have not adopted a policy that all compensation must qualify as deductible under Section 162(m). Amounts paid under our compensation programs may not be
deductible as the result of Section 162(m). While our policy is generally to preserve corporate tax deductions by qualifying compensation over $1 million paid to executive officers as performance-based, the Compensation Committee may, from
time to time, conclude that compensation arrangements are in our best interests and the best interests of our shareholders despite the fact that such arrangements might not, in whole or part, qualify for tax deductibility. We intend to design our
executive compensation arrangements to be consistent with our best interests and the interests of our shareholders. To the extent we determine it to be consistent with our best interests and the interests of our shareholders, we intend to preserve,
to the extent practicable, the applicability of the transition rule to awards that were granted on or before October 2, 2017. However, there is no guaranty that such transition status can or will be applicable.

REPORT OF THE COMPENSATION & BENEFITS COMMITTEE

The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy
statement. Based on this review and discussion, the committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated by reference into the Companys Annual
Report on Form 10-K for the year ended December 31, 2017.

The following table summarizes for the years ended December 31, 2017, 2016 and 2015, as applicable, the total compensation of our
NEOsour Chief Executive Officer, Chief Financial Officer, and our three other most highly compensated executive officers.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

Name and Principal

Position

Year

Salary ($)

Bonus

($)

StockAwards

(1)

($)

OptionAwards(1)

($)

Non-EquityIncentive
PlanCompensation (2)($)

Change
inPensionValue and

Non-QualifiedDeferredCompensationEarnings (3)($)

All
OtherCompensation(4)

($)

Total

($)

P. Cody Phipps (5)

Chairman, President & Chief Executive
Officer

2017

2016

2015

$

922,500

915,577

443,117

$





1,125,000

$

5,000,001

3,999,994

7,000,022

$







$

383,991

1,083,939

217,125







$

375,543

263,869

107,292

$

6,682,035

6,263,379

8,892,556

Richard A. Meier (6)

Executive Vice

President, CFO &

President, International

2017

2016

2015

$

653,162

648,260

614,765

$







$

1,050,044

699,999

1,632,526

$







$

163,127

460,480

471,154







$

299,116

155,869

182,896

$

2,165,449

1,964,608

2,901,341

Stuart Morris-Hipkins

Executive Vice President, Global Manufacturer
Services

2017

2016

2015

$

335,096





$

100,000





$

1,335,037





$







$

91,730











$

67,331





$

1,926,194





Charles C. Colpo

Senior Vice President,

Strategic Supplier Management

2017

2016

2015

$

456,895

453,466

471,739

$







$

467,979

311,994

390,002

$







$

76,073

214,742

265,892

$



225,265



$

829,467

535,319

623,499

$

1,830,414

1,740,786

1,751,132

Rony C. Kordahi

Executive Vice President, North American Operations

2017

2016

2015

$

450,000

328,846



$







$

1,050,044

1,099,993



$







$

104,895

222,076









$

52,334

71,592



$

1,657,273

1,722,507



(1) The amounts included in column (e) are the aggregate grant date fair value of the awards computed
in accordance with FASB ASC Topic 718, and column (e) includes awards subject to performance conditions. Of the total awards reflected in column (e) for 2017, the amount specified below for each officer represents awards subject to
performance conditions, which are valued at the grant date based on probable achievement at target levels:

For Mr. Phipps, the 2015 amount includes a
one-time sign on grant of $5,000,006 of restricted stock. For Mr. Meier, the 2015 amount includes a special grant of $1,000,009 of restricted stock. For Mr. Kordahi, the 2016
amount includes a sign-on grant of $400,011 of restricted stock. For Mr. Morris-Hipkins, the 2017 amount includes a sign-on grant of
$285,004 of restricted stock.

Assumptions used in the calculation of the stock awards included in column (e) are
included in note 12 to the consolidated financial statements included in the Companys Annual Report on Form 10-K for the year ended December 31, 2017, which is incorporated herein by reference. The
actual value an NEO may receive for stock awards depends on market prices, and there can be no assurance that the amounts shown are the amounts that will be realized.

(2) The amounts included in column (g) reflect cash awards to the NEOs under the Companys performance-based annual incentive programs for 2017, 2016 and 2015. Mr. Morris-Hipkins 2017
cash award is pro-rated based on time in position during 2017 (10 months). Further information on awards made under the 2017 Annual Incentive Program is provided under Compensation Discussion and
AnalysisAnnual Incentives on page 43 of this proxy statement.

(3) The amounts included in column (h) reflect
the actuarial increase in the present value of the NEOs benefits under the Companys Supplemental Executive Retirement Plan (SERP) during 2017, 2016 and 2015 determined using interest rate and mortality rate assumptions
consistent with those used in the Companys financial statements. SERP benefits were frozen effective March 31, 2012, and none of Messrs. Phipps, Meier, Morris-Hipkins and Kordahi participate in the SERP. For additional information on
the Companys retirement plans, see Retirement Plans on page 59 of this proxy statement. No NEO received preferential or above-market earnings on deferred compensation.

(4) For 2017, the amounts included in column (i) consist of the following benefits or Company contributions attributable to the
following:

Mr. Meiers other compensation represents relocation costs paid by the Company in 2017.

(c)

Mr. Morris-Hipkinss other compensation represents relocation costs paid by the Company in 2017.

(d)

Included in Mr. Colpos other compensation are the following amounts paid or attributed to him in connection with his temporary relocation to the United
Kingdom to manage our European operations: $540,864 in tax equalization payments, $97,036 in gross-up payments, $79,451 in housing allowance and related costs, and $21,905 in cost of living allowance.

Mr. Morris-Hipkins joined the Company as Executive Vice President, Global Manufacturer Services, on March 13, 2017.

(f)

Unless otherwise provided with respect to an NEO, includes miscellaneous amenities and/or awards provided at Company sales and leadership conferences and other awards
or gifts.

(5) Mr. Phipps joined the Company as its President & Chief Executive officer effective
July 1, 2015.

(6) Mr. Meier assumed the additional role of President, International effective July 1, 2015.

(7) The amounts included in column (d) reflect special or guaranteed bonus payments. As part of his offer of employment,
Mr.
Morris-Hipkins received a sign-on cash bonus of $100,000.

GRANTS
OF PLAN BASED AWARDS TABLE

The following table shows awards granted to the NEOs during the year ended December 31,
2017.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

Name

GrantDate

Estimated Future Payouts UnderNon-Equity Incentive Plan Awards

(1)

Estimated Potential Payouts UnderEquity Incentive Plan Awards

(2)

All OtherStockAwards:NumberofSharesof StockorUnits (3)(#)

All OtherOptionAwards:Number ofSecuritiesUnderlyingOptions (4)(#)

Exerciseor BasePrice ofOptionAwards($ /Sh)

GrantDateFairValue ofStockandOptionAwards(5)

Threshold($)

Target($)

Maximum($)

Threshold(#)

Target(#)

Maximum(#)

P. Cody Phipps

2/9/17







1

55,695

111,390







$

2,000,007

2/9/17













55,695





2,000,007

2/9/17









27,847

55,694







999,986

N/A

$

403,594

$

864,844

$

2,306,250















Richard A.
Meier

2/9/17







1

9,747

19,494







$

350,015

2/9/17









9,747

19,494







350,015

2/9/17













9,747





350,015

N/A

$171,455

$367,404

$979,743















Stuart Morris-Hipkins

3/13/17







1





9,777





$

350,017

3/13/17













7,961





285,004

3/13/17









9,777

19,554







350,017

5/5/17









10,674

21,348







350,000

N/A

$104,125

$223,125

$595,000















Charles C.
Colpo

2/9/17







1





4,344





$

155,993

2/9/17









4,344

8,688







155,993

2/9/17









4,344

8,688







155,993

N/A

$79,957

$171,336

$456,895















Rony C.
Kordahi

2/9/17













9,747





$

350,015

2/9/17







1

9,747

19,494







350,015

2/9/17









9,747

19,494







350,015

N/A

$110,250

$236,250

$630,000















(1) The amounts shown in column (c) reflect the minimum payment level under the Companys 2017
Annual Incentive Program if minimum performance conditions were met and represents 47% of the target payment level shown in column (d) which is based on meeting target performance conditions. The amount shown in column (e) is 200% of the
target payment level and is based on meeting maximum performance conditions. These amounts are based upon the individuals 2017 salary and position (125% of base salary for Mr. Phipps,

75% of base salary for Mr. Meier, 70% of base salary for Mr. Stuart Morris-Hipkins, 50% of base salary for Mr. Colpo, and 70% of base salary for Mr. Kordahi). Payouts under
the 2017 Annual Incentive Program are set forth in the Summary Compensation Table under Non-Equity Incentive Plan Compensation on page 54 of this proxy statement.

(2) The amounts shown in column (f) reflect the minimum restricted stock award level under 2017 performance share grants if minimum
performance conditions are met. The target restricted stock award level shown in column (g) is based on meeting target performance conditions and the maximum level shown in column (h) is 200% of the target restricted stock award level and
is based on meeting the maximum performance conditions. These restricted stock awards are based on the Companys achievement of average return on capital employed and adjusted diluted EPS goals for 2017 and 2018 as discussed on page 48 of this
proxy statement and, if earned, vest on the third anniversary of the performance share grant. Dividends are not paid on performance share grants unless and until the performance conditions are satisfied, resulting in the issuance of the underlying
restricted stock.

(3) The amounts shown in column (i) represent grants of restricted stock that vest one to five years
from the date of grant based on the executives continued employment with the Company. Dividends are paid on outstanding restricted stock grants at the same rate as for all shareholders of record.

(4) No stock options were granted by the Company in 2017.

(5) The amounts shown in column (l) are the grant date fair value of each individual equity award computed in accordance with FASB ASC Topic 718.

(1) Shares of restricted stock vest fully either three or five years from the date of grant. Vesting
dates for the shares of restricted stock listed for each officer range from January 2018 to July 2020.

(2) The market value
of the restricted shares was calculated based on $18.88 per share, the closing price of the Companys Common Stock on December 31, 2017. Dividends are paid on outstanding shares of restricted stock at the same rate as paid to all
shareholders of record.

(3) The amounts in column (i) represent the number of performance shares outstanding based on
the achievement of the target level of performance conditions. The market value of the performance shares was calculated based on $18.88 per share, the closing price of the Companys Common Stock on December 31, 2017. Dividends are not
paid on performance shares unless and until the underlying performance conditions are achieved.